| 1 | (11C)PE2I | - | - | - | - | 1件: 6 6 💬
|
| 2 | (2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide) | - | - | - | - | 1件: 6 6 💬
|
| 3 | (3aR,8aS)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-ol | - | - | - | - | 1件: 6 6 💬
|
| 4 | (3aR,8aS)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-ol phenylcarbamate, (2S,3S)-2,3-dihydroxybutanedioate (1:1) | - | - | - | - | 1件: 6 6 💬
|
| 5 | (3beta, 5beta, 25R)-spirostan-3-ol | - | - | - | - | 1件: 6 6 💬
|
| 6 | (3ß, 5ß, 25R)-spirostan-3-ol | - | - | - | - | 1件: 6 6 💬
|
| 7 | (6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol | - | - | - | - | 1件: 6 6 💬
|
| 8 | (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate | - | - | - | - | 1件: 6 6 💬
|
| 9 | (R)-troloxamide quinone | - | - | - | - | 1件: 6 6 💬
|
| 10 | (S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol | - | - | - | - | 1件: 6 6 💬
|
| 11 | (S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate | - | - | - | - | 1件: 6 6 💬
|
| 12 | 0 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: Tropicamide
Tropicamide
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 13 | 0.04 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 14 | 0.08 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 15 | 0.2 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 16 | 0.3 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: Tropicamide
Tropicamide
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 17 | 0.4 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 18 | 0.5~1ug/kg/min remifentanil combined with 0.2~0.5mg/kg/h esketamine for the physiological testing phase of DBS surgery. | 2件: Esketamine Esketamine, Remifentanil | 4件: Remifentanil hydrochloride
Remifentanil hydrochloride
,
Esketamine
,
Remifentanil
,
Esketamine hydrochloride
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, OPRM1 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Estrogen signaling pathway, Glutamatergic synapse, Hormone signaling, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 19 | 0.6 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 20 | 0.8 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 21 | 0.9% saline | - | - | - | - | 2件: 6 6, 70 💬
|
| 22 | 0.9% sodium chloride | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 5件: 6 6, 14, 51, 53, 96 💬
|
| 23 | 0.9% sodium chloride (normal saline) | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 2件: 6 6, 85 💬
|
| 24 | 00000 | - | - | - | - | 2件: 6 6, 96 💬
|
| 25 | 000000 | - | - | - | - | 1件: 6 6 💬
|
| 26 | 009-0 | - | - | - | - | 1件: 6 6 💬
|
| 27 | 009-1 | - | - | - | - | 1件: 6 6 💬
|
| 28 | 009-2 | - | - | - | - | 1件: 6 6 💬
|
| 29 | 009-3 | - | - | - | - | 1件: 6 6 💬
|
| 30 | 009-4 | - | - | - | - | 1件: 6 6 💬
|
| 31 | 009-5 | - | - | - | - | 1件: 6 6 💬
|
| 32 | 009-A0 | - | - | - | - | 1件: 6 6 💬
|
| 33 | 009-A1 | - | - | - | - | 1件: 6 6 💬
|
| 34 | 009-A2 | - | - | - | - | 1件: 6 6 💬
|
| 35 | 009-A3 | - | - | - | - | 1件: 6 6 💬
|
| 36 | 1 mg QD to 15 mg QD PF-06649751 | - | - | - | - | 1件: 6 6 💬
|
| 37 | 1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study) | - | - | - | - | 1件: 6 6 💬
|
| 38 | 1 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: Tropicamide
Tropicamide
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 39 | 1. Tesofensine (NS 2330) | 1件: Tesofensine Tesofensine | - | - | - | 1件: 6 6 💬
|
| 40 | 1.0 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 41 | 1.0 mg rasagiline mesylate | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAOB MAOB 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 42 | 1.2 mg Lu AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 43 | 100 | - | - | - | - | 2件: 6 6, 97 💬
|
| 44 | 11C-MC1 | - | - | - | - | 2件: 6 6, 13 💬
|
| 45 | 11C-Methylreboxetine (11C-MRB) | - | - | - | - | 2件: 6 6, 17 💬
|
| 46 | 11C-PBR28 | - | - | - | - | 2件: 6 6, 13 💬
|
| 47 | 11C-PiB | - | - | - | - | 2件: 6 6, 13 💬
|
| 48 | 11C-PS13 | - | - | - | - | 2件: 6 6, 13 💬
|
| 49 | 11C-Raclopride | 1件: Raclopride Raclopride | - | - | - | 1件: 6 6 💬
|
| 50 | 125 | - | - | - | - | 1件: 6 6 💬
|
| 51 | 13N-Ammonia | 1件: Ammonia Ammonia | 1件: Ammonia solution, strong
Ammonia solution, strong
💬
| - | - | 2件: 6 6, 17 💬
|
| 52 | 15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD | - | - | - | - | 1件: 6 6 💬
|
| 53 | 15 mg QD PF-06649751 | - | - | - | - | 1件: 6 6 💬
|
| 54 | 15-0 H20 | - | - | - | - | 2件: 6 6, 19 💬
|
| 55 | 150% of their routine home dopaminergic medications dose right in the clinic | - | - | - | - | 1件: 6 6 💬
|
| 56 | 15O H2O | - | - | - | - | 1件: 6 6 💬
|
| 57 | 18-FDTBZ | - | - | - | - | 1件: 6 6 💬
|
| 58 | 18F florbetaben | - | - | - | - | 1件: 6 6 💬
|
| 59 | 18F- DTBZ | - | - | - | - | 1件: 6 6 💬
|
| 60 | 18F-AV-133 | - | - | - | - | 1件: 6 6 💬
|
| 61 | 18F-AV-45 | - | - | - | - | 2件: 6 6, 127 💬
|
| 62 | 18F-DOPA | - | - | - | - | 3件: 6 6, 17, 75 💬
|
| 63 | 18F-DOPA PET | - | - | - | - | 1件: 6 6 💬
|
| 64 | 18F-Dopamine | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 17 💬
|
| 65 | 18F-DTBZ | - | - | - | - | 1件: 6 6 💬
|
| 66 | 18F-DTBZ AV-133 | - | - | - | - | 1件: 6 6 💬
|
| 67 | 18F-FDG | - | - | - | - | 3件: 6 6, 127, 300 💬
|
| 68 | 18f-florbetaben | - | - | - | - | 1件: 6 6 💬
|
| 69 | 18F-Fluoro-L-dopa | - | - | - | - | 1件: 6 6 💬
|
| 70 | 18F-MFBG | - | - | - | - | 1件: 6 6 💬
|
| 71 | 18F-OP-801 | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 72 | 18F-SMBT-1 | - | - | - | - | 1件: 6 6 💬
|
| 73 | 1[(6- Allyl- 8beta- erg | - | - | - | - | 1件: 6 6 💬
|
| 74 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 💬
|
| 75 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 💬
|
| 76 | 1[(6- Allyl- 8ß- erg | - | - | - | - | 1件: 6 6 💬
|
| 77 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 💬
|
| 78 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 💬
|
| 79 | 2 mg perampanel | 1件: Perampanel Perampanel | 2件: Perampanel
Perampanel
,
Perampanel hydrate
💬
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬
| 17件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 80 | 2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide | - | - | - | - | 1件: 6 6 💬
|
| 81 | 2-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE | - | - | - | - | 2件: 6 6, 162 💬
|
| 82 | 200 mg BIA 6-512 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 83 | 207-3120 | - | - | - | - | 1件: 6 6 💬
|
| 84 | 240mg Amantadine HCl ER tablets | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 85 | 25 mg BIA9 1067 | - | - | - | - | 1件: 6 6 💬
|
| 86 | 25 mg Ongentys | - | - | - | - | 1件: 6 6 💬
|
| 87 | 25330 | - | - | - | - | 1件: 6 6 💬
|
| 88 | 3 mg QD to 15 mg QD PF-06649751 | - | - | - | - | 1件: 6 6 💬
|
| 89 | 3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | - | - | - | - | 1件: 6 6 💬
|
| 90 | 3 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: Tropicamide
Tropicamide
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 91 | 3- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate | - | - | - | - | 1件: 6 6 💬
|
| 92 | 3-(3,4-Dihydroxyphenyl)-L-alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 1件: 6 6 💬
|
| 93 | 320mg Amantadine HCl ER tablets | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 94 | 4 mg perampanel | 1件: Perampanel Perampanel | 2件: Perampanel
Perampanel
,
Perampanel hydrate
💬
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬
| 17件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 95 | 5-year Follow-up DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 💬
|
| 96 | 50 mg BIA 9 1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 97 | 50 mg Ongentys | - | - | - | - | 1件: 6 6 💬
|
| 98 | 6-[18F]Fluorodopa | - | - | - | - | 1件: 6 6 💬
|
| 99 | 6-[18F]Fluorodopamine | - | - | - | - | 1件: 6 6 💬
|
| 100 | 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 101 | 6aß - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 102 | 7 mg QD to 15 mg QD PF-06649751 | - | - | - | - | 1件: 6 6 💬
|
| 103 | 7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | - | - | - | - | 1件: 6 6 💬
|
| 104 | 7-beta-Hydroxyepiandrosterone | 1件: 7-beta-Hydroxyepiandrosterone 7-beta-Hydroxyepiandrosterone | - | - | - | 1件: 6 6 💬
|
| 105 | 75 | - | - | - | - | 1件: 6 6 💬
|
| 106 | [023145028] | - | - | - | - | 1件: 6 6 💬
|
| 107 | [043906039] | - | - | - | - | 1件: 6 6 💬
|
| 108 | [11C]-CS1P1 | - | - | - | - | 1件: 6 6 💬
|
| 109 | [11C]-PIB | - | - | - | - | 1件: 6 6 💬
|
| 110 | [11C]MODAG-005 | - | - | - | - | 2件: 6 6, 17 💬
|
| 111 | [11C]PBR28 | - | - | - | - | 1件: 6 6 💬
|
| 112 | [11C]PXT012253 | - | - | - | - | 1件: 6 6 💬
|
| 113 | [11C]SMW139 | - | - | - | - | 1件: 6 6 💬
|
| 114 | [123I] 5-IA | - | - | - | - | 1件: 6 6 💬
|
| 115 | [123I] IBVM and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 116 | [123I] mZINT injection and serial dynamic SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 117 | [123I]-IBVM | - | - | - | - | 1件: 6 6 💬
|
| 118 | [123I]-IBZM imaging | - | - | - | - | 1件: 6 6 💬
|
| 119 | [123I]B-CIT | - | - | - | - | 1件: 6 6 💬
|
| 120 | [123I]B-CIT SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 121 | [123I]beta CIT | - | - | - | - | 1件: 6 6 💬
|
| 122 | [123I]beta CIT and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 123 | [123I]beta-CIT | - | - | - | - | 1件: 6 6 💬
|
| 124 | [123I]beta-CIT and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 125 | [123I]CLINDE | - | - | - | - | 2件: 6 6, 13 💬
|
| 126 | [123I]MNI-420 | - | - | - | - | 2件: 6 6, 8 💬
|
| 127 | [123I]ß CIT | - | - | - | - | 1件: 6 6 💬
|
| 128 | [123I]ß CIT and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 129 | [123I]ß-CIT | - | - | - | - | 1件: 6 6 💬
|
| 130 | [123I]ß-CIT and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 131 | [14C]-BIA 9-1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 132 | [15O]H2O | - | - | - | - | 1件: 6 6 💬
|
| 133 | [18683-91-5] | - | - | - | - | 1件: 6 6 💬
|
| 134 | [18F] AV-133 PET Imaging | - | - | - | - | 1件: 6 6 💬
|
| 135 | [18F] CFPyPB | - | - | - | - | 1件: 6 6 💬
|
| 136 | [18F] LBT-999 | - | - | - | - | 1件: 6 6 💬
|
| 137 | [18F] LBT-999 PET | - | - | - | - | 1件: 6 6 💬
|
| 138 | [18F] PBR06 | - | - | - | - | 2件: 6 6, 13 💬
|
| 139 | [18F] PI-2620 | - | - | - | - | 1件: 6 6 💬
|
| 140 | [18F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane | - | - | - | - | 1件: 6 6 💬
|
| 141 | [18F]-FEPPA | - | - | - | - | 2件: 6 6, 13 💬
|
| 142 | [18F]DPA-714 PET scan | - | - | - | - | 1件: 6 6 💬
|
| 143 | [18F]FDOPA | - | - | - | - | 2件: 6 6, 17 💬
|
| 144 | [18F]FDOPA PET/CT | - | - | - | - | 1件: 6 6 💬
|
| 145 | [18F]FE-PE2I | - | - | - | - | 1件: 6 6 💬
|
| 146 | [18F]FPEB | - | - | - | - | 3件: 6 6, 8, 206 💬
|
| 147 | [18F]MC225 | - | - | - | - | 1件: 6 6 💬
|
| 148 | [18F]MK-0947 | - | - | - | - | 1件: 6 6 💬
|
| 149 | [18F]MK-9470 | - | - | - | - | 1件: 6 6 💬
|
| 150 | [18F]MNI-1126 | - | - | - | - | 1件: 6 6 💬
|
| 151 | [18F]MNI-1216 | - | - | - | - | 1件: 6 6 💬
|
| 152 | [18F]MPPF | - | - | - | - | 1件: 6 6 💬
|
| 153 | [18F]NOS | - | - | - | - | 1件: 6 6 💬
|
| 154 | [18F]P17-059 | - | - | - | - | 1件: 6 6 💬
|
| 155 | [18F]PI-2620 | - | - | - | - | 2件: 6 6, 127 💬
|
| 156 | [18F]T807 ([18F]MNI-777) | - | - | - | - | 2件: 5 5, 6 💬
|
| 157 | [18F]UCB-2897 | - | - | - | - | 1件: 6 6 💬
|
| 158 | [21CFR640.30] Plasma from 18 - 25 year old volunteer donors | - | - | - | - | 1件: 6 6 💬
|
| 159 | [6036937.00.01] | - | - | - | - | 1件: 6 6 💬
|
| 160 | [ABBV-951] | - | - | - | - | 1件: 6 6 💬
|
| 161 | [ANVS401] | - | - | - | - | 1件: 6 6 💬
|
| 162 | [APL-130277] | - | - | - | - | 1件: 6 6 💬
|
| 163 | [BIA 9-1067] | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 164 | [BIIB054] | - | - | - | - | 1件: 6 6 💬
|
| 165 | [citicolin] | - | - | - | - | 1件: 6 6 💬
|
| 166 | [CVL-751] | - | - | - | - | 1件: 6 6 💬
|
| 167 | [DaTSCAN] | - | - | - | - | 1件: 6 6 💬
|
| 168 | [DNL151, DN0001575, DN1575] | - | - | - | - | 1件: 6 6 💬
|
| 169 | [DNL151] | - | - | - | - | 1件: 6 6 💬
|
| 170 | [F-18] Fluorodopa Positron Emission Tomography | - | - | - | - | 1件: 6 6 💬
|
| 171 | [F-18]DPA714 administration IV | - | - | - | - | 1件: 6 6 💬
|
| 172 | [IPX203] | - | - | - | - | 1件: 6 6 💬
|
| 173 | [IR CD-LD] | - | - | - | - | 1件: 6 6 💬
|
| 174 | [IRL790] | - | - | - | - | 1件: 6 6 💬
|
| 175 | [JM-010] | - | - | - | - | 1件: 6 6 💬
|
| 176 | [JNJ31-31001074] | - | - | - | - | 1件: 6 6 💬
|
| 177 | [N04BA] | - | - | - | - | 1件: 6 6 💬
|
| 178 | [N06AX26] | - | - | - | - | 1件: 6 6 💬
|
| 179 | [NA] | - | - | - | - | 34件: 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 180 | [ND0612] | - | - | - | - | 1件: 6 6 💬
|
| 181 | [RO7046015] | - | - | - | - | 1件: 6 6 💬
|
| 182 | [TD-9855] | - | - | - | - | 2件: 6 6, 17 💬
|
| 183 | [UCB0599] | - | - | - | - | 1件: 6 6 💬
|
| 184 | [¹8F]MODAG-009 PET imaging | - | - | - | - | 2件: 6 6, 17 💬
|
| 185 | A-DOPAMINE | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 186 | Aadipose-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 6 6 💬
|
| 187 | AAV2-GDNF | - | - | - | - | 1件: 6 6 💬
|
| 188 | AAV2-GDNF gene therapy | - | - | - | - | 2件: 6 6, 17 💬
|
| 189 | AAV2-hAADC | - | - | - | - | 1件: 6 6 💬
|
| 190 | AB-1005 | - | - | - | - | 1件: 6 6 💬
|
| 191 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 192 | ABBV-0805 | - | - | - | - | 1件: 6 6 💬
|
| 193 | ABBV-951 | - | - | - | - | 1件: 6 6 💬
|
| 194 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 💬
|
| 195 | ABT-SLV187 | - | - | - | - | 1件: 6 6 💬
|
| 196 | Acamprosate | 1件: Acamprosate Acamprosate | 2件: Acamprosate calcium
Acamprosate calcium
,
Acamprosate
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 206 💬
|
| 197 | Accordion Pill Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 198 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 199 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 200 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 201 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 202 | Accordion Pill¿ Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 203 | Accordion Pill™ Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 204 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 205 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 206 | Acetate | 1件: Acetate Acetate | - | - | - | 52件: 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 207 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 25件: 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 208 | ACI-7104.056 at Dose A | - | - | - | - | 1件: 6 6 💬
|
| 209 | ACI-7104.056 at Dose B (optional) | - | - | - | - | 1件: 6 6 💬
|
| 210 | ACI-7104.056 at Dose C (optional) | - | - | - | - | 1件: 6 6 💬
|
| 211 | ACP-103 | - | - | - | - | 1件: 6 6 💬
|
| 212 | ACR325 | - | - | - | - | 1件: 6 6 💬
|
| 213 | ActiMyo recording | - | - | - | - | 1件: 6 6 💬
|
| 214 | Active comparator | - | - | - | - | 3件: 6 6, 46, 96 💬
|
| 215 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | 1件: 6 6 💬
|
| 216 | Active drug: pimavanserin 17mg (2 strength tablets) | 1件: Pimavanserin Pimavanserin | 1件: Pimavanserin tartrate
Pimavanserin tartrate
💬
| 2件: HTR2A HTR2A, HTR2C 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 217 | Active Investigational Treatment ENT-01 | - | - | - | - | 1件: 6 6 💬
|
| 218 | Active tDCS | - | - | - | - | 1件: 6 6 💬
|
| 219 | Active tPCS | - | - | - | - | 1件: 6 6 💬
|
| 220 | Active Transcranial Direct Current Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 221 | Adaptor: Hakko Adaptor | - | - | - | - | 1件: 6 6 💬
|
| 222 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 💬
|
| 223 | Administration of Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 17 💬
|
| 224 | Administration of stable isotope-labelled leucine- | 1件: Leucine Leucine | 1件: Leucine
Leucine
💬
| - | - | 1件: 6 6 💬
|
| 225 | ADS-5102 | - | - | - | - | 2件: 6 6, 13 💬
|
| 226 | ADS-5102 (extended release amantadine HCl) | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 227 | ADX48621 | - | - | - | - | 1件: 6 6 💬
|
| 228 | AFFITOPE® PD01A | - | - | - | - | 1件: 6 6 💬
|
| 229 | AFFITOPE® PD01A + Adjuvant | - | - | - | - | 2件: 6 6, 17 💬
|
| 230 | AFQ056 | - | - | - | - | 3件: 6 6, 8, 206 💬
|
| 231 | AFQ056 with L-dopa | - | - | - | - | 1件: 6 6 💬
|
| 232 | AFQ065 | - | - | - | - | 1件: 6 6 💬
|
| 233 | AGB101 | - | - | - | - | 1件: 6 6 💬
|
| 234 | Agomelatine | 1件: Agomelatine Agomelatine | 1件: Agomelatine
Agomelatine
💬
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 235 | Agomelatine or PIacebo | 1件: Agomelatine Agomelatine | 1件: Agomelatine
Agomelatine
💬
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 236 | AKST4290 | - | - | - | - | 2件: 6 6, 162 💬
|
| 237 | Alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 8件: 6 6, 13, 70, 94, 97, 251, 298, 299 💬
|
| 238 | ALC01 therapy | - | - | - | - | 1件: 6 6 💬
|
| 239 | Alcoholic drink | - | - | - | - | 1件: 6 6 💬
|
| 240 | AlloEx | - | - | - | - | 1件: 6 6 💬
|
| 241 | Allogeneic bone marrow-derived mesenchymal stem cells | - | - | - | - | 1件: 6 6 💬
|
| 242 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬
|
| 243 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬
|
| 244 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬
|
| 245 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬
|
| 246 | Allogeneic dopaminergic neural precursor cell(iDAP) | - | - | - | - | 1件: 6 6 💬
|
| 247 | Allogeneic dopaminergic neural precursor cell(NCR201) | - | - | - | - | 1件: 6 6 💬
|
| 248 | Allogeneic embryonic stem cell-derived ventral midbrain dopaminergic progenitor cells | - | - | - | - | 1件: 6 6 💬
|
| 249 | Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High Dose | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 250 | Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 251 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_High Dose | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 252 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_Low Dose | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 253 | Allopregnanolone | - | - | - | - | 2件: 6 6, 205 💬
|
| 254 | Allopurinol | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 255 | ALN-SNCA | - | - | - | - | 1件: 6 6 💬
|
| 256 | Alovudine | 1件: Alovudine Alovudine | 1件: Alovudine
Alovudine
💬
| - | - | 1件: 6 6 💬
|
| 257 | Altanserin | 1件: Altanserin Altanserin | - | - | - | 1件: 6 6 💬
|
| 258 | Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 259 | Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 260 | Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 261 | Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 262 | Altropane | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬
|
| 263 | Altropane (123I) Injection | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬
|
| 264 | ALTROPANE® | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬
|
| 265 | Amantadin-ratiopharm 100mg | - | - | - | - | 1件: 6 6 💬
|
| 266 | Amantadine | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 5件: 2 2, 6, 8, 13, 127 💬
|
| 267 | Amantadine (100mg) as add on therapy. | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 268 | Amantadine 300 mg | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 269 | Amantadine HCl ER | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 270 | Amantadine HCl Extended Release | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 271 | Amantadine HCl Extended Release Capsule | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 272 | AMANTADINE HYDROCHLORIDE | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
| 273 | Amantadine hydrochloride (HCl) | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 274 | Amantadine sulfate | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 275 | AMBROSAN 60mg Tablets | - | - | - | - | 1件: 6 6 💬
|
| 276 | Ambroxol | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 3件: 2 2, 6, 19 💬
|
| 277 | AMBROXOL CLORIDRATO | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 6 6 💬
|
| 278 | Ambroxol Hydrochloride | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 2件: 6 6, 19 💬
|
| 279 | Ambroxol Hydrochloride (420mg) | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 6 6 💬
|
| 280 | AMDX2011P | - | - | - | - | 2件: 2 2, 6 💬
|
| 281 | Amino acid supplement | - | - | - | - | 2件: 6 6, 46 💬
|
| 282 | Amino acids | 1件: Amino acids Amino acids | - | - | - | 6件: 6 6, 70, 90, 113, 240, 298 💬
|
| 283 | Ammonia | 1件: Ammonia Ammonia | 1件: Ammonia solution, strong
Ammonia solution, strong
💬
| - | - | 6件: 6 6, 17, 86, 88, 251, 296 💬
|
| 284 | Amoxicillin | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 9件: 6 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
|
| 285 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
| 286 | Ampreloxetine chydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
| 287 | Ampreloxetine hydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
| 288 | Ampyra first, | - | - | - | - | 1件: 6 6 💬
|
| 289 | AMS2434 (amino acids) | 1件: Amino acids Amino acids | - | - | - | 1件: 6 6 💬
|
| 290 | ANAVEX2-73 | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 156 💬
|
| 291 | ANHYDROUS CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 292 | Anle138b | - | - | - | - | 1件: 6 6 💬
|
| 293 | ANPD001 | - | - | - | - | 1件: 6 6 💬
|
| 294 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 💬
|
| 295 | Anti-Parkinsonian Drugs | - | - | - | - | 1件: 6 6 💬
|
| 296 | Antiparkinsonian Agent(s) | - | - | - | - | 1件: 6 6 💬
|
| 297 | ANVS401 | - | - | - | - | 1件: 6 6 💬
|
| 298 | AP-472 | - | - | - | - | 1件: 6 6 💬
|
| 299 | AP-CD/LD | - | - | - | - | 1件: 6 6 💬
|
| 300 | AP09004 | - | - | - | - | 1件: 6 6 💬
|
| 301 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 3件: 6 6, 46, 97 💬
|
| 302 | APL-130277 | - | - | - | - | 1件: 6 6 💬
|
| 303 | Aplindore | 1件: Aplindore Aplindore | 1件: Aplindore fumarate
Aplindore fumarate
💬
| 2件: DRD2 DRD2, DRD3 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 304 | Aplindore MR tablets | 1件: Aplindore Aplindore | 1件: Aplindore fumarate
Aplindore fumarate
💬
| 2件: DRD2 DRD2, DRD3 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 305 | APO-go | - | - | - | - | 1件: 6 6 💬
|
| 306 | APO-go® | - | - | - | - | 1件: 6 6 💬
|
| 307 | APOKINON | - | - | - | - | 1件: 6 6 💬
|
| 308 | APOKYN | - | - | - | - | 1件: 6 6 💬
|
| 309 | Apomor | - | - | - | - | 1件: 6 6 💬
|
| 310 | APOMORFINA CLORIDRATO | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 311 | Apomorp | - | - | - | - | 1件: 6 6 💬
|
| 312 | Apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 💬
|
| 313 | Apomorphine 0.25% (2.5mg/ml) | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 314 | Apomorphine Cartridge | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 315 | Apomorphine HCl injection | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 316 | APOMORPHINE HYDROCHLORIDE | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 317 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 318 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 319 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 320 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 321 | APOMORPHINE HYDROCHLORIDE HEMIHYDRATE | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 322 | Apomorphine Hydrocloride | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 323 | Apomorphine Hydrocloride Hemihydrate | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 324 | Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 325 | Apomorphine Injectable Solution | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 326 | Apomorphine Nasal Powder | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 327 | Apomorphine pump | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 328 | APORON | - | - | - | - | 1件: 6 6 💬
|
| 329 | AQW051 | - | - | - | - | 1件: 6 6 💬
|
| 330 | ARICEPT | - | - | - | - | 3件: 6 6, 13, 124 💬
|
| 331 | Aricept 5 mg-Filmtabletten | - | - | - | - | 1件: 6 6 💬
|
| 332 | Aricept 5mg-Filmtabletten | - | - | - | - | 1件: 6 6 💬
|
| 333 | Aripiprazole | 1件: Aripiprazole Aripiprazole | 1件: Aripiprazole
Aripiprazole
💬
| 4件: DRD2 DRD2, DRD3, HTR1A, HTR2A 💬
| 14件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 74, 206 💬
|
| 334 | Armodafinil | 1件: Armodafinil Armodafinil | 1件: Armodafinil
Armodafinil
💬
| 1件: SLC6A3 SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 💬
|
| 335 | AS2 | - | - | - | - | 1件: 6 6 💬
|
| 336 | ASK Nr. 21972 | - | - | - | - | 2件: 5 5, 6 💬
|
| 337 | ASyn Mab | - | - | - | - | 1件: 6 6 💬
|
| 338 | ATH-1017 | - | - | - | - | 1件: 6 6 💬
|
| 339 | ATM FOG in PD | - | - | - | - | 1件: 6 6 💬
|
| 340 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: Atomoxetine hydrochloride
Atomoxetine hydrochloride
,
Atomoxetine
💬
| 1件: SLC6A2 SLC6A2 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 💬
|
| 341 | Atypical Antipsychotics | - | - | - | - | 1件: 6 6 💬
|
| 342 | Autologous dopaminergic cell implantation | - | - | - | - | 1件: 6 6 💬
|
| 343 | Autologous induced neural stem cell-derived DA precursor cells | - | - | - | - | 1件: 6 6 💬
|
| 344 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 💬
|
| 345 | Autologous midbrain dopamine neurons | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 346 | Autonomic testing on and off levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 347 | AV-101 | 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 💬
|
| 348 | AV1451 Tau | - | - | - | - | 3件: 6 6, 17, 127 💬
|
| 349 | AVALOX - 400 | - | - | - | - | 1件: 6 6 💬
|
| 350 | AVE8112 | - | - | - | - | 1件: 6 6 💬
|
| 351 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 352 | AVP-923-45 | - | - | - | - | 1件: 6 6 💬
|
| 353 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 26件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 354 | AZD0328 | - | - | - | - | 1件: 6 6 💬
|
| 355 | AZD3241 | - | - | - | - | 2件: 6 6, 17 💬
|
| 356 | AZD3241 300 mg BID | - | - | - | - | 1件: 6 6 💬
|
| 357 | AZD3241 600 mg BID | - | - | - | - | 1件: 6 6 💬
|
| 358 | AZD3241 Alternative titration scheme with formulation 1 or 2 | - | - | - | - | 1件: 6 6 💬
|
| 359 | AZD3241 ER formulation 1 | - | - | - | - | 1件: 6 6 💬
|
| 360 | AZD3241 Extended release tablets 100 mg | - | - | - | - | 1件: 6 6 💬
|
| 361 | AZD3241 Extended release tablets 25 mg | - | - | - | - | 1件: 6 6 💬
|
| 362 | Azilect | - | - | - | - | 3件: 5 5, 6, 17 💬
|
| 363 | AZILECT 1 mg comprimidos | - | - | - | - | 2件: 6 6, 17 💬
|
| 364 | Azilect 1mg | - | - | - | - | 1件: 6 6 💬
|
| 365 | AZILECT® | - | - | - | - | 1件: 6 6 💬
|
| 366 | B-STN DBS | - | - | - | - | 1件: 6 6 💬
|
| 367 | B6, B12, L-methylfolate | - | - | - | - | 1件: 6 6 💬
|
| 368 | Bacillus coagulans | 1件: Bacillus coagulans Bacillus coagulans | - | - | - | 1件: 6 6 💬
|
| 369 | Bacillus licheniformis | 1件: Bacillus licheniformis Bacillus licheniformis | - | - | - | 1件: 6 6 💬
|
| 370 | Bacillus Subtilis | 1件: Bacillus subtilis Bacillus subtilis | - | - | - | 3件: 6 6, 28, 96 💬
|
| 371 | Barium | 1件: Barium Barium | - | - | - | 5件: 2 2, 6, 19, 97, 98 💬
|
| 372 | Bavisant | 1件: Bavisant Bavisant | 1件: Bavisant
Bavisant
💬
| 1件: HRH3 HRH3 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 373 | Bavisant dihydrochloride monohydrate | 1件: Bavisant Bavisant | 1件: Bavisant
Bavisant
💬
| 1件: HRH3 HRH3 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 374 | BAVISANT HYDROCHLORIDE MONOHYDRATE | 1件: Bavisant Bavisant | 1件: Bavisant
Bavisant
💬
| 1件: HRH3 HRH3 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 375 | BBM-P002 | - | - | - | - | 1件: 6 6 💬
|
| 376 | Bee venom | - | - | - | - | 1件: 6 6 💬
|
| 377 | BEFIRADOL | 1件: Befiradol Befiradol | - | - | - | 1件: 6 6 💬
|
| 378 | Behavioral: assessment during the transition between OFF-levodopa (i.e. withdrawal of levodopa phase) and ON-levodopa (i.e. effect of Levodopa phase)states | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 379 | Behavioral: Assessment of cognition | - | - | - | - | 1件: 6 6 💬
|
| 380 | Behavioral: Assessment of depression | - | - | - | - | 1件: 6 6 💬
|
| 381 | Behavioral: Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors | - | - | - | - | 1件: 6 6 💬
|
| 382 | Behavioral: Assessment of quality of life | - | - | - | - | 2件: 6 6, 97 💬
|
| 383 | Behavioral: Assessment of severity of ICD (impulse control disorders) | - | - | - | - | 1件: 6 6 💬
|
| 384 | Behavioral: Assessment of severity of Parkinson Disease | - | - | - | - | 1件: 6 6 💬
|
| 385 | Behavioral: Assessments in ON and OFF levodopa state | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 386 | Behavioral: Balance & Strengthening Exercises | - | - | - | - | 1件: 6 6 💬
|
| 387 | Behavioral: Balance Training | - | - | - | - | 3件: 6 6, 13, 18 💬
|
| 388 | Behavioral: Brisk walking and balance training | - | - | - | - | 1件: 6 6 💬
|
| 389 | Behavioral: CBT and sleep hygiene | - | - | - | - | 1件: 6 6 💬
|
| 390 | Behavioral: Clinical Assessment | - | - | - | - | 1件: 6 6 💬
|
| 391 | Behavioral: Combined balance and brisk walking training | - | - | - | - | 1件: 6 6 💬
|
| 392 | Behavioral: Complex task practice | - | - | - | - | 1件: 6 6 💬
|
| 393 | Behavioral: Comprehensive rehabilitation | - | - | - | - | 1件: 6 6 💬
|
| 394 | Behavioral: Conservative Measures for Orthostatic Hypotension | - | - | - | - | 2件: 6 6, 17 💬
|
| 395 | Behavioral: Conventional Balance exercise | - | - | - | - | 1件: 6 6 💬
|
| 396 | Behavioral: Cycling Intervention | - | - | - | - | 1件: 6 6 💬
|
| 397 | Behavioral: Dexterity | - | - | - | - | 1件: 6 6 💬
|
| 398 | Behavioral: Exercise | - | - | - | - | 6件: 6 6, 46, 113, 265, 299, 344 💬
|
| 399 | Behavioral: Exercise-based behavioral therapy | - | - | - | - | 1件: 6 6 💬
|
| 400 | Behavioral: Flexibility and strengthening exercise | - | - | - | - | 1件: 6 6 💬
|
| 401 | Behavioral: Gait and balance | - | - | - | - | 1件: 6 6 💬
|
| 402 | Behavioral: gait and balance training program | - | - | - | - | 1件: 6 6 💬
|
| 403 | Behavioral: Gait and balance training with dual-task (six weeks) | - | - | - | - | 1件: 6 6 💬
|
| 404 | Behavioral: Gait and balance training with dual-task (twelve weeks: 6 +6) | - | - | - | - | 1件: 6 6 💬
|
| 405 | Behavioral: Gait and balance training with dual-task + action observation and motor imagery (six weeks) | - | - | - | - | 1件: 6 6 💬
|
| 406 | Behavioral: Gait and balance training with dual-task + action observation and motor imagery (twelve weeks: 6 + 6) | - | - | - | - | 1件: 6 6 💬
|
| 407 | Behavioral: Healthy age-matched controls | - | - | - | - | 1件: 6 6 💬
|
| 408 | Behavioral: Levodopa or acupuncture | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 409 | Behavioral: Low-load resistance training with blood flow restriction | - | - | - | - | 1件: 6 6 💬
|
| 410 | Behavioral: Mediterranean-Ketogenic Diet | - | - | - | - | 1件: 6 6 💬
|
| 411 | Behavioral: Memory | - | - | - | - | 1件: 6 6 💬
|
| 412 | Behavioral: OM Meditation | - | - | - | - | 1件: 6 6 💬
|
| 413 | Behavioral: Participant open-response writing | - | - | - | - | 1件: 6 6 💬
|
| 414 | Behavioral: Participant self-assessment surveys | - | - | - | - | 1件: 6 6 💬
|
| 415 | Behavioral: Pelvic floor muscle exercise-based behavioral therapy | - | - | - | - | 1件: 6 6 💬
|
| 416 | Behavioral: Phonation | - | - | - | - | 1件: 6 6 💬
|
| 417 | Behavioral: Physical Therapy | - | - | - | - | 2件: 6 6, 13 💬
|
| 418 | Behavioral: Psychosocial intervention | - | - | - | - | 1件: 6 6 💬
|
| 419 | Behavioral: Questionnaires and Clinical Assessments | - | - | - | - | 1件: 6 6 💬
|
| 420 | Behavioral: Rehabilitation therapy | - | - | - | - | 1件: 6 6 💬
|
| 421 | Behavioral: Resistance Training | - | - | - | - | 1件: 6 6 💬
|
| 422 | Behavioral: Role of dopamine | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 423 | Behavioral: Split-belt treadmill training | - | - | - | - | 1件: 6 6 💬
|
| 424 | Behavioral: Static balance exercise | - | - | - | - | 1件: 6 6 💬
|
| 425 | Behavioral: stretching | - | - | - | - | 2件: 6 6, 13 💬
|
| 426 | Behavioral: Structured wellness care | - | - | - | - | 1件: 6 6 💬
|
| 427 | Behavioral: Upper limb exercise | - | - | - | - | 1件: 6 6 💬
|
| 428 | Behavioral: Voice, Speech and Language Analysis | - | - | - | - | 1件: 6 6 💬
|
| 429 | Bemdaneprocel | - | - | - | - | 1件: 6 6 💬
|
| 430 | BEN-2001 | - | - | - | - | 1件: 6 6 💬
|
| 431 | BENSERAZIDE | 1件: Benserazide Benserazide | 2件: Benserazide hydrochloride
Benserazide hydrochloride
,
Benserazide
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 432 | BENSERAZIDE HYDROCHLORIDE | 1件: Benserazide Benserazide | 2件: Benserazide hydrochloride
Benserazide hydrochloride
,
Benserazide
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 433 | Benzofuran | 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 💬
|
| 434 | Berachin | - | - | - | - | 1件: 6 6 💬
|
| 435 | Best Medical Treatment | - | - | - | - | 1件: 6 6 💬
|
| 436 | Best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group Recommendations | - | - | - | - | 1件: 6 6 💬
|
| 437 | Best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper | - | - | - | - | 1件: 6 6 💬
|
| 438 | Best médical treatment | - | - | - | - | 1件: 6 6 💬
|
| 439 | Best oral medication | - | - | - | - | 1件: 6 6 💬
|
| 440 | Betaquik MCT supplement | - | - | - | - | 1件: 6 6 💬
|
| 441 | BF 2.649 | - | - | - | - | 1件: 6 6 💬
|
| 442 | BF 2.649 10 mg | - | - | - | - | 1件: 6 6 💬
|
| 443 | BF 2.649 20 mg | - | - | - | - | 1件: 6 6 💬
|
| 444 | BF 2.649 40 mg | - | - | - | - | 1件: 6 6 💬
|
| 445 | BF 2.649 5 mg | - | - | - | - | 1件: 6 6 💬
|
| 446 | BF2.649 | - | - | - | - | 1件: 6 6 💬
|
| 447 | BF2.649 (Pitolisant) | 1件: Pitolisant Pitolisant | 2件: Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| 1件: HRH3 HRH3 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 448 | BHV-8000 | - | - | - | - | 1件: 6 6 💬
|
| 449 | BI-Sifrol® | - | - | - | - | 1件: 6 6 💬
|
| 450 | BIA | 1件: BIA BIA | - | - | - | 4件: 6 6, 86, 96, 299 💬
|
| 451 | BIA 28-6156 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 452 | BIA 28-6156 10 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 453 | BIA 28-6156 60 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 454 | BIA 3-202 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 455 | BIA 3-202 (200 mg) | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 456 | BIA 6-512 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 457 | BIA 6-512 100 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 458 | BIA 6-512 100 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 459 | BIA 6-512 200 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 460 | BIA 6-512 25 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 461 | BIA 6-512 25 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 462 | BIA 6-512 400 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 463 | BIA 6-512 50 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 464 | BIA 9-1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 465 | BIA 9-1067 (test) | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 466 | BIA 9-1067 15 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 467 | BIA 9-1067 25 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 468 | BIA 9-1067 30 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 469 | BIA 9-1067 5 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 470 | BIA 9-1067 micronized | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 471 | BIA 9-1067 non-micronized | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 472 | BIIB014 | - | - | - | - | 1件: 6 6 💬
|
| 473 | BIIB054 | - | - | - | - | 1件: 6 6 💬
|
| 474 | BIIB094 | - | - | - | - | 1件: 6 6 💬
|
| 475 | BIIB122 | - | - | - | - | 1件: 6 6 💬
|
| 476 | BIIB122 225 mg | - | - | - | - | 1件: 6 6 💬
|
| 477 | Bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper | - | - | - | - | 1件: 6 6 💬
|
| 478 | Bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatment | - | - | - | - | 1件: 6 6 💬
|
| 479 | Bioactivated GRA for adult patients | - | - | - | - | 2件: 6 6, 13 💬
|
| 480 | Bioactivated GRA for pediatric patients | - | - | - | - | 2件: 6 6, 13 💬
|
| 481 | Biofluid samplings | - | - | - | - | 1件: 6 6 💬
|
| 482 | Biological/Vaccine: Allogeneic HB-adMSCs | - | - | - | - | 1件: 6 6 💬
|
| 483 | Bisphosphonates | - | - | - | - | 2件: 6 6, 274 💬
|
| 484 | Blood analysis | - | - | - | - | 1件: 6 6 💬
|
| 485 | Blood Brain Barrier Disruption - Functional | - | - | - | - | 1件: 6 6 💬
|
| 486 | Blood draw | - | - | - | - | 16件: 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 487 | Blood flow restriction (BFR) and aerobic exercise via recumbent stepping (Nu-Step) | - | - | - | - | 1件: 6 6 💬
|
| 488 | Blood pressure measurement | - | - | - | - | 1件: 6 6 💬
|
| 489 | Blood sample | - | - | - | - | 33件: 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 490 | Blood test | - | - | - | - | 19件: 2 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
|
| 491 | BMS-9894923 | - | - | - | - | 1件: 6 6 💬
|
| 492 | Bone marrow derived mesenchymal stem cells | - | - | - | - | 2件: 6 6, 60 💬
|
| 493 | BoNT-A | - | - | - | - | 1件: 6 6 💬
|
| 494 | BOTOX | - | - | - | - | 5件: 6 6, 13, 36, 149, 226 💬
|
| 495 | Botulinum Toxin | - | - | - | - | 3件: 6 6, 13, 149 💬
|
| 496 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 4件: Botulinum toxin type A
Botulinum toxin type A
,
OnabotulinumtoxinA
,
AbobotulinumtoxinA
,
Incobotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 13件: 2 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
|
| 497 | Botulinum toxin type A injection | 1件: Botulinum toxin type A Botulinum toxin type A | 4件: Botulinum toxin type A
Botulinum toxin type A
,
OnabotulinumtoxinA
,
AbobotulinumtoxinA
,
Incobotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 498 | Botulinum toxin type B | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: RimabotulinumtoxinB
RimabotulinumtoxinB
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 51 💬
|
| 499 | Botulinum toxin type B (Myobloc) | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: RimabotulinumtoxinB
RimabotulinumtoxinB
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 2 2, 6 💬
|
| 500 | Botulinum Toxin: Xeomin | - | - | - | - | 1件: 6 6 💬
|
| 501 | Brintellix | - | - | - | - | 1件: 6 6 💬
|
| 502 | BRINTELLIX - 20 MG/ML - GOCCE ORALI, SOLUZIONE - USO ORALE - FLACONE (VETRO) 15 ML - 1 FLACONE | - | - | - | - | 1件: 6 6 💬
|
| 503 | BROMOCRIPTINE | 1件: Bromocriptine Bromocriptine | 2件: Bromocriptine mesylate
Bromocriptine mesylate
,
Bromocriptine
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 57, 74 💬
|
| 504 | Bromocriptine and other dopamine agonists | 2件: Bromocriptine Bromocriptine, Dopamine | 4件: Dopamine hydrochloride
Dopamine hydrochloride
,
Bromocriptine mesylate
,
Bromocriptine
,
Dopamine
💬
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 505 | BTRX-246040 | 1件: BTRX-246040 BTRX-246040 | - | - | - | 1件: 6 6 💬
|
| 506 | Bumetanide | 1件: Bumetanide Bumetanide | 1件: Bumetanide
Bumetanide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 4件: 6 6, 57, 115, 158 💬
|
| 507 | Bumetanide white, oblong, scored tablet | 1件: Bumetanide Bumetanide | 1件: Bumetanide
Bumetanide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 💬
|
| 508 | Buntanetap | - | - | - | - | 1件: 6 6 💬
|
| 509 | Buntanetap Tartrate [(+)-phenserine D-tartrate] | 1件: Phenserine Phenserine | - | - | - | 1件: 6 6 💬
|
| 510 | Buntanetap/posiphen | 1件: Posiphen Posiphen | 1件: Buntanetap
Buntanetap
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 511 | Bupleurum+Ginkgo | - | - | - | - | 1件: 6 6 💬
|
| 512 | Buspirone | 1件: Buspirone Buspirone | 2件: Buspirone hydrochloride
Buspirone hydrochloride
,
Buspirone
💬
| 2件: DRD2 DRD2, HTR1A 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 💬
|
| 513 | BUSPIRONE CLORIDRATO | 1件: Buspirone Buspirone | 2件: Buspirone hydrochloride
Buspirone hydrochloride
,
Buspirone
💬
| 2件: DRD2 DRD2, HTR1A 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 514 | Buspirone Hydrochloride | 1件: Buspirone Buspirone | 2件: Buspirone hydrochloride
Buspirone hydrochloride
,
Buspirone
💬
| 2件: DRD2 DRD2, HTR1A 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 515 | Butylphthalide | 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 17, 22 💬
|
| 516 | BYDUREON | - | - | - | - | 2件: 6 6, 17 💬
|
| 517 | Bydureon 2 mg powder and solvent for prolonged-release suspension | - | - | - | - | 1件: 6 6 💬
|
| 518 | Byetta 5 micrograms | - | - | - | - | 1件: 6 6 💬
|
| 519 | C-11 ER176 | - | - | - | - | 3件: 6 6, 17, 127 💬
|
| 520 | C-11 PiB | - | - | - | - | 3件: 6 6, 17, 127 💬
|
| 521 | C11-SY08 | - | - | - | - | 2件: 6 6, 17 💬
|
| 522 | Cabaser | - | - | - | - | 2件: 6 6, 77 💬
|
| 523 | Cabaseril | - | - | - | - | 1件: 6 6 💬
|
| 524 | Cabaseril, 1,0 mg Tablette | - | - | - | - | 1件: 6 6 💬
|
| 525 | Cabaseril, 2,0 mg Tablette | - | - | - | - | 1件: 6 6 💬
|
| 526 | CABERGOLINA | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 75 💬
|
| 527 | Cabergoline | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 6 6, 74, 75, 77 💬
|
| 528 | CADD-Legacy ambulatory infusion pump | - | - | - | - | 1件: 6 6 💬
|
| 529 | CADD-Legacy® 1400 ambulatory infusion pump | - | - | - | - | 1件: 6 6 💬
|
| 530 | Caffeine | 1件: Caffeine Caffeine | 2件: Caffeine
Caffeine
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 531 | Caffeine 100-200 mg BID | 1件: Caffeine Caffeine | 2件: Caffeine
Caffeine
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 532 | Caffeine alkaloid | 1件: Caffeine Caffeine | 2件: Caffeine
Caffeine
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 533 | Calcium | 1件: Calcium Calcium | - | - | - | 39件: 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 534 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 20件: 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 535 | Cannabidiol (CBD) | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 7件: 6 6, 13, 140, 144, 145, 156, 158 💬
|
| 536 | Cannabidiol 100 mg/ml | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 537 | Cannabidiol 300 mg/ml | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 538 | Cannabidiol 400 mg/ml | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 539 | Cannabis Oil | - | - | - | - | 1件: 6 6 💬
|
| 540 | Cannabis, Medical | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
| 541 | Capsaicin | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 5件: 2 2, 6, 19, 86, 226 💬
|
| 542 | Capsaicin vapor | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 543 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 544 | Carbamazepine | 1件: Carbamazepine Carbamazepine | 1件: Carbamazepine
Carbamazepine
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 6件: 6 6, 13, 137, 145, 158, 231 💬
|
| 545 | CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 6 6, 13, 17, 90, 140, 164, 201 💬
|
| 546 | CARBIDOPA (CD) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 547 | CARBIDOPA (FU) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 548 | Carbidopa 20 mg | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 549 | Carbidopa 200mg oral dose | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 550 | Carbidopa 25/Levodopa 100Mg Tab | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 551 | Carbidopa 27.5 mg | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 552 | Carbidopa 65 mg capsule | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 553 | Carbidopa and Levodopa Controlled Release Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 554 | Carbidopa and Levodopa Tablets, USP | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 555 | CARBIDOPA ANIDRA | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 556 | CARBIDOPA FU | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 557 | CARBIDOPA INN | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 558 | CARBIDOPA LEVODOPA | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 559 | CARBIDOPA MONOHYDRATE | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 560 | Carbidopa Pill | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 561 | Carbidopa, levodopa, entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 562 | Carbidopa- Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 563 | Carbidopa-4'-Monophosphate | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 564 | Carbidopa-Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 565 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 566 | Carbidopa/l-dopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 567 | Carbidopa/l-dopa/entacapone | 2件: Carbidopa Carbidopa, Entacapone | 2件: Carbidopa
Carbidopa
,
Entacapone
💬
| 2件: COMT COMT, DDC 💬
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 568 | Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 569 | Carbidopa/levodopa, as prescribed by treating physician | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 570 | Carbidopa/Levodopa, immediate release | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 571 | Carbidopa/Levodopa/Entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 572 | Carbidopamonohydraat | - | - | - | - | 1件: 6 6 💬
|
| 573 | CARBODOPA LEVADOPA | - | - | - | - | 1件: 6 6 💬
|
| 574 | Carbodopa/levadopa | - | - | - | - | 1件: 6 6 💬
|
| 575 | Carbon Fiber Ankle Foot Orthosis (AFO) | - | - | - | - | 1件: 6 6 💬
|
| 576 | Carbon-14 BIA 28-6156 | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 577 | Cardiac monitoring | - | - | - | - | 1件: 6 6 💬
|
| 578 | Carfentanil | 1件: Carfentanil Carfentanil | 2件: Carfentanil citrate
Carfentanil citrate
,
Carfentanil
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 579 | Carnosine | 1件: Carnosine Carnosine | - | - | - | 2件: 6 6, 13 💬
|
| 580 | Carnosine supplementation | 1件: Carnosine Carnosine | - | - | - | 1件: 6 6 💬
|
| 581 | Carvedilol | 1件: Carvedilol Carvedilol | 2件: Carvedilol
Carvedilol
,
Carvedilol phosphate
💬
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
| 15件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 46, 57, 58, 86, 113, 210 💬
|
| 582 | Catapres ampoules | - | - | - | - | 1件: 6 6 💬
|
| 583 | CD-LD CR | - | - | - | - | 1件: 6 6 💬
|
| 584 | CD-LD IR | - | - | - | - | 1件: 6 6 💬
|
| 585 | CDNF | - | - | - | - | 1件: 6 6 💬
|
| 586 | Ceftriaxone | 1件: Ceftriaxone Ceftriaxone | 2件: Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | 4件: 2 2, 6, 97, 299 💬
|
| 587 | CELECOXIB | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 14件: 2 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 588 | Celecoxib 200mg | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 6 6 💬
|
| 589 | CEP-1347 | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 💬
|
| 590 | CEP-1347 10mg | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 💬
|
| 591 | CEP-1347 50mg | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 💬
|
| 592 | CEP1347 | - | - | - | - | 1件: 6 6 💬
|
| 593 | CEP1347 25mg | - | - | - | - | 1件: 6 6 💬
|
| 594 | CERE-120 | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
| 595 | CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
| 596 | CERE-120: Adeno-Associated Virus Delivery of Neurturin | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
| 597 | Cerebral Dopamine Neurotrophic Factor | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 598 | Ceretec | - | - | - | - | 1件: 6 6 💬
|
| 599 | CERETEC (TM) Estabilizado | - | - | - | - | 1件: 6 6 💬
|
| 600 | Chamomile | 1件: Chamomile Chamomile | 1件: German chamomile flower
German chamomile flower
💬
| - | - | 1件: 6 6 💬
|
| 601 | Champix | - | - | - | - | 1件: 6 6 💬
|
| 602 | Chinese herbal medicine treatment | - | - | - | - | 1件: 6 6 💬
|
| 603 | Chocolate | - | - | - | - | 1件: 6 6 💬
|
| 604 | Cilostazol | 1件: Cilostazol Cilostazol | 1件: Cilostazol
Cilostazol
💬
| 3件: PDE3A PDE3A, PDE3B, TBXA2R 💬
| 13件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 13, 46, 48, 51, 70, 124 💬
|
| 605 | CIPRALEX | - | - | - | - | 1件: 6 6 💬
|
| 606 | Circadin® | - | - | - | - | 1件: 6 6 💬
|
| 607 | Citalopram | 1件: Citalopram Citalopram | 2件: Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 💬
|
| 608 | Citalopram 20mg | 1件: Citalopram Citalopram | 2件: Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 609 | CITICOLIN*1G/4ML IM IV 5 F | - | - | - | - | 1件: 6 6 💬
|
| 610 | Citicolina 1000 mg/die | - | - | - | - | 1件: 6 6 💬
|
| 611 | CITICOLINA SODICA | - | - | - | - | 1件: 6 6 💬
|
| 612 | CJH1 (CLR4001) | - | - | - | - | 1件: 6 6 💬
|
| 613 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 10件: 6 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
|
| 614 | Clarithromycin (Not used as of 4/2020) | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 1件: 6 6 💬
|
| 615 | Clarium 50 mg Retardtabletten | - | - | - | - | 1件: 6 6 💬
|
| 616 | Clartihromycin, amoxicillin, and omeprazole | 2件: Amoxicillin Amoxicillin, Omeprazole | 6件: Amoxicillin
Amoxicillin
,
Omeprazole
,
Omeprazole sodium
,
Amoxicillin sodium
,
Omeprazole magnesium
,
Amoxicillin
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 6 6 💬
|
| 617 | CLE | - | - | - | - | 1件: 6 6 💬
|
| 618 | Clenbuterol | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 1 1, 2, 6, 57, 113, 256 💬
|
| 619 | Clenbuterol HCl | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 620 | CLENBUTEROL HYDROCHLORIDE | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 621 | Clinical DBS Setting | - | - | - | - | 1件: 6 6 💬
|
| 622 | Clonazepam | 1件: Clonazepam Clonazepam | 1件: Clonazepam
Clonazepam
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 9件: Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
| 623 | Clonidine | 1件: Clonidine Clonidine | 2件: Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 65, 70 💬
|
| 624 | Clonidine hydrochloride | 1件: Clonidine Clonidine | 2件: Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 625 | CLOZAPINE | 1件: Clozapine Clozapine | 1件: Clozapine
Clozapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 626 | Coarse wheat bran | 2件: Wheat Wheat, Wheat bran | 1件: Wheat
Wheat
💬
| - | - | 1件: 6 6 💬
|
| 627 | Cocoa | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬
|
| 628 | Coenzym Q10 Nanodispersion | - | - | - | - | 2件: 5 5, 6 💬
|
| 629 | Coenzym Q10, Ubiquinon, Ubichinon | - | - | - | - | 2件: 5 5, 6 💬
|
| 630 | Coenzyme Q10 | - | - | - | - | 11件: 2 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
|
| 631 | Coenzyme Q10 Nanodispersion (Nanoquinone) | - | - | - | - | 1件: 6 6 💬
|
| 632 | Coenzyme Q10 with vitamin E | 1件: Vitamin E Vitamin E | 1件: Vitamin E
Vitamin E
💬
| - | - | 1件: 6 6 💬
|
| 633 | Cogane™ (PYM50028) | - | - | - | - | 1件: 6 6 💬
|
| 634 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 35件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 💬
|
| 635 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 35件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 💬
|
| 636 | Collection of biological sample (blood and/or CSF) | - | - | - | - | 2件: 2 2, 6 💬
|
| 637 | Combination injection of EPO and G-CSF | - | - | - | - | 1件: 6 6 💬
|
| 638 | Combination Product: Fecal Microbiota Transplant | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 6 6 💬
|
| 639 | Combination Product: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001) | - | - | - | - | 1件: 6 6 💬
|
| 640 | Combination Product: INBRIJA® | - | - | - | - | 1件: 6 6 💬
|
| 641 | Combination Product: L-dopa 140 mg | - | - | - | - | 1件: 6 6 💬
|
| 642 | Combination Product: L-dopa 35 mg | - | - | - | - | 1件: 6 6 💬
|
| 643 | Combination Product: L-dopa 70mg | - | - | - | - | 1件: 6 6 💬
|
| 644 | Combination Product: L-dopa 70mg/carbidopa 7mg | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 645 | Combination Product: Levodopa Cyclops® | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 646 | Combination Product: ND0612 Solution for SC infusion | - | - | - | - | 1件: 6 6 💬
|
| 647 | Comparator: carbidopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 648 | Comparator: levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 649 | COMTAN | - | - | - | - | 1件: 6 6 💬
|
| 650 | COMTAN 200* 60 CPR 200 MG | - | - | - | - | 1件: 6 6 💬
|
| 651 | COMTAN® | - | - | - | - | 1件: 6 6 💬
|
| 652 | Comtan® | - | - | - | - | 1件: 6 6 💬
|
| 653 | Comtess | - | - | - | - | 1件: 6 6 💬
|
| 654 | Comtess® | - | - | - | - | 1件: 6 6 💬
|
| 655 | Conscious sedation | - | - | - | - | 1件: 6 6 💬
|
| 656 | Continuous Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 657 | Continuous intrajejunal infusion of levodopa-carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 658 | Continuous Release Dopamine Agonists | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 659 | Continuous Subcutaneous Lisuride Infusion | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 660 | Control | - | - | - | - | 8件: 2 2, 6, 46, 51, 90, 97, 168, 299 💬
|
| 661 | Control surgery | - | - | - | - | 1件: 6 6 💬
|
| 662 | Controlled-release levodopa / carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 663 | Conventional medication | - | - | - | - | 1件: 6 6 💬
|
| 664 | CoQ10 | - | - | - | - | 4件: 5 5, 6, 8, 96 💬
|
| 665 | CPL500036 | - | - | - | - | 1件: 6 6 💬
|
| 666 | CPL500036 - high dose | - | - | - | - | 1件: 6 6 💬
|
| 667 | CPL500036 - low dose | - | - | - | - | 1件: 6 6 💬
|
| 668 | Creatine | 1件: Creatine Creatine | - | - | - | 18件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
|
| 669 | CREXONT ER | - | - | - | - | 1件: 6 6 💬
|
| 670 | Crisugabalin | 1件: Crisugabalin Crisugabalin | - | - | - | 2件: 6 6, 13 💬
|
| 671 | Crocin | 1件: Crocin Crocin | - | - | - | 1件: 6 6 💬
|
| 672 | Crocin and Apigenin | 2件: Apigenin Apigenin, Crocin | - | - | - | 1件: 6 6 💬
|
| 673 | CST-103 | - | - | - | - | 1件: 6 6 💬
|
| 674 | CST-107 | - | - | - | - | 1件: 6 6 💬
|
| 675 | CST-139 | - | - | - | - | 1件: 6 6 💬
|
| 676 | Cu(II)ATSM | - | - | - | - | 2件: 2 2, 6 💬
|
| 677 | Custom Device | - | - | - | - | 1件: 6 6 💬
|
| 678 | Customized microinjection device | - | - | - | - | 1件: 6 6 💬
|
| 679 | CVD00118-E | - | - | - | - | 1件: 6 6 💬
|
| 680 | CVL-751 | - | - | - | - | 1件: 6 6 💬
|
| 681 | CVN424 | - | - | - | - | 1件: 6 6 💬
|
| 682 | CVN424 150 mg | - | - | - | - | 1件: 6 6 💬
|
| 683 | CVN424 75 mg | - | - | - | - | 1件: 6 6 💬
|
| 684 | CVT-301 | - | - | - | - | 1件: 6 6 💬
|
| 685 | CVT-301 (Dose Level 1) | - | - | - | - | 1件: 6 6 💬
|
| 686 | CVT-301 (Dose Level 2) | - | - | - | - | 1件: 6 6 💬
|
| 687 | CVT-301 35mg | - | - | - | - | 1件: 6 6 💬
|
| 688 | CVT-301 50mg | - | - | - | - | 1件: 6 6 💬
|
| 689 | CVT-301 High Dose | - | - | - | - | 1件: 6 6 💬
|
| 690 | CVT-301 Low Dose | - | - | - | - | 1件: 6 6 💬
|
| 691 | CVT-301, LIP | - | - | - | - | 1件: 6 6 💬
|
| 692 | CVXL-0107 | - | - | - | - | 1件: 6 6 💬
|
| 693 | CX-8998 | - | - | - | - | 1件: 6 6 💬
|
| 694 | CyberKnife | - | - | - | - | 1件: 6 6 💬
|
| 695 | CYMBALTA | - | - | - | - | 3件: 6 6, 13, 49 💬
|
| 696 | CYR-064 | - | - | - | - | 1件: 6 6 💬
|
| 697 | Cysteine | 1件: Cysteine Cysteine | 2件: L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | 13件: 6 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
|
| 698 | Cystoscopic injection of Botox into the urinary bladder | - | - | - | - | 1件: 6 6 💬
|
| 699 | D-Serine | 2件: D-Serine D-Serine, Serine | 1件: Serine
Serine
💬
| - | - | 1件: 6 6 💬
|
| 700 | D-serine (~2g/day) | 2件: D-Serine D-Serine, Serine | 1件: Serine
Serine
💬
| - | - | 1件: 6 6 💬
|
| 701 | DA-9701 | - | - | - | - | 1件: 6 6 💬
|
| 702 | DA-9805 45mg | - | - | - | - | 1件: 6 6 💬
|
| 703 | DA-9805 90mg | - | - | - | - | 1件: 6 6 💬
|
| 704 | DAAOI-P | - | - | - | - | 1件: 6 6 💬
|
| 705 | Dacepton 5 mg/ml | - | - | - | - | 1件: 6 6 💬
|
| 706 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | 1件: 6 6 💬
|
| 707 | Daily ingestion of Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 💬
|
| 708 | Dapagliflozin | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 16件: 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 709 | Dapansutrile | 1件: Dapansutrile Dapansutrile | 1件: Dapansutrile
Dapansutrile
💬
| - | - | 1件: 6 6 💬
|
| 710 | Daridorexant | 1件: Daridorexant Daridorexant | 2件: Daridorexant
Daridorexant
,
Daridorexant hydrochloride
💬
| 2件: HCRTR1 HCRTR1, HCRTR2 💬
| 2件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 711 | Darifenacin | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 4件: 2 2, 6, 13, 26 💬
|
| 712 | Dark chocolate (85% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬
|
| 713 | DaTSCAN | - | - | - | - | 3件: 2 2, 5, 6 💬
|
| 714 | DaTSCAN 74 MBq/ml solution for injection | - | - | - | - | 1件: 6 6 💬
|
| 715 | DATscan and SPECT imaging | - | - | - | - | 1件: 6 6 💬
|
| 716 | DaTSCAN™ | - | - | - | - | 1件: 6 6 💬
|
| 717 | DBS Setting Maximizing Prefrontal Activation | - | - | - | - | 1件: 6 6 💬
|
| 718 | DBS Setting Minimizing Prefrontal Activation | - | - | - | - | 1件: 6 6 💬
|
| 719 | DC158AM | - | - | - | - | 1件: 6 6 💬
|
| 720 | Deanol | 1件: Deanol Deanol | 1件: Deanol
Deanol
💬
| - | - | 1件: 6 6 💬
|
| 721 | Deanol pyroglutamate | 1件: Deanol Deanol | 1件: Deanol
Deanol
💬
| - | - | 1件: 6 6 💬
|
| 722 | DEBRUMYL | - | - | - | - | 1件: 6 6 💬
|
| 723 | Deep Brain Stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 💬
|
| 724 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 7件: 2 2, 6, 18, 121, 122, 139, 233 💬
|
| 725 | Deferiprone (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 2件: 6 6, 139 💬
|
| 726 | Deferiprone 20mg | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 727 | Deferiprone 30mg | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 728 | Deferiprone 600 mg delayed release tablet | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 729 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 2件: 2 2, 6 💬
|
| 730 | Desmopressin | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 8件: 6 6, 22, 64, 72, 75, 223, 225, 288 💬
|
| 731 | Desmopressin Acetat | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 6 6 💬
|
| 732 | Desmotabs | - | - | - | - | 1件: 6 6 💬
|
| 733 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | 1件: 6 6 💬
|
| 734 | Desmotabs® 0,2mg Tabletten | - | - | - | - | 1件: 6 6 💬
|
| 735 | Determination of drug effects through amantadine cessation | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 736 | Dexdor | - | - | - | - | 4件: 2 2, 4, 6, 70 💬
|
| 737 | DEXMEDETOMIDINA | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 738 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
| 739 | Dexmedetomidine Hydrochloride Infusion | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 740 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Dextromethorphan polistirex
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 10件: 2 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
|
| 741 | Diagnostic Test: 123I-MIBG | - | - | - | - | 1件: 6 6 💬
|
| 742 | Diagnostic Test: [123I] MIBG scintigraphy of the heart | - | - | - | - | 1件: 6 6 💬
|
| 743 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | 6件: 2 2, 5, 6, 7, 17, 127 💬
|
| 744 | Diagnostic Test: a-synuclein seeding amplification assays | - | - | - | - | 1件: 6 6 💬
|
| 745 | Diagnostic Test: Assessment of dynamic EEG features over 48-hour periods across all study aims | - | - | - | - | 1件: 6 6 💬
|
| 746 | Diagnostic Test: Beam test to predict falls | - | - | - | - | 1件: 6 6 💬
|
| 747 | Diagnostic Test: Blood samples | - | - | - | - | 4件: 6 6, 49, 56, 235 💬
|
| 748 | Diagnostic Test: Blood test and clinical examination. | - | - | - | - | 1件: 6 6 💬
|
| 749 | Diagnostic Test: brain imaging | - | - | - | - | 1件: 6 6 💬
|
| 750 | Diagnostic Test: Cognitive Battery | - | - | - | - | 1件: 6 6 💬
|
| 751 | Diagnostic Test: computerized dynamic posturography | - | - | - | - | 1件: 6 6 💬
|
| 752 | Diagnostic Test: Dopamine transporter PET scan with [18F]FE-PE2I | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 753 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | 6件: 2 2, 5, 6, 7, 17, 127 💬
|
| 754 | Diagnostic Test: Electroencephalogram | - | - | - | - | 2件: 6 6, 127 💬
|
| 755 | Diagnostic Test: electromyography | - | - | - | - | 2件: 2 2, 6 💬
|
| 756 | Diagnostic Test: Ewing's tests | - | - | - | - | 1件: 6 6 💬
|
| 757 | Diagnostic Test: Examination of vibration perception threshold in fingertips | - | - | - | - | 1件: 6 6 💬
|
| 758 | Diagnostic Test: FDG-PET | - | - | - | - | 1件: 6 6 💬
|
| 759 | Diagnostic Test: Fluoro[18F]promethazine | 1件: Promethazine Promethazine | 3件: Promethazine hydrochloride
Promethazine hydrochloride
,
Promethazine
,
Promethazine teoclate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 760 | Diagnostic Test: Flutemetamol F18 Injection | 1件: Flutemetamol Flutemetamol | - | - | - | 6件: 2 2, 5, 6, 7, 17, 127 💬
|
| 761 | Diagnostic Test: Inertial measurement Unite | - | - | - | - | 1件: 6 6 💬
|
| 762 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | 6件: 2 2, 5, 6, 7, 17, 127 💬
|
| 763 | Diagnostic Test: Magnetic resonance imaging (MRI) | - | - | - | - | 1件: 6 6 💬
|
| 764 | Diagnostic Test: Measurement of serum level of anti-dementia drug | - | - | - | - | 1件: 6 6 💬
|
| 765 | Diagnostic Test: Motion Capture system | - | - | - | - | 1件: 6 6 💬
|
| 766 | Diagnostic Test: Multi modal MRI | - | - | - | - | 1件: 6 6 💬
|
| 767 | Diagnostic Test: Neuropsycological assesment | - | - | - | - | 1件: 6 6 💬
|
| 768 | Diagnostic Test: Oral Glucose Tolerance Test | - | - | - | - | 6件: 6 6, 13, 57, 65, 77, 299 💬
|
| 769 | Diagnostic Test: Plasma biomarkers | - | - | - | - | 1件: 6 6 💬
|
| 770 | Diagnostic Test: Polar H10 Heart Sensor | - | - | - | - | 1件: 6 6 💬
|
| 771 | Diagnostic Test: Polysomnography | - | - | - | - | 1件: 6 6 💬
|
| 772 | Diagnostic Test: Sham Comparator: Controls | - | - | - | - | 1件: 6 6 💬
|
| 773 | Diagnostic Test: Smell test | - | - | - | - | 1件: 6 6 💬
|
| 774 | Diagnostic Test: Thermography | - | - | - | - | 1件: 6 6 💬
|
| 775 | Diagnostic Test: Tilt table test | - | - | - | - | 1件: 6 6 💬
|
| 776 | Diagnostic Test: Virtual reality | - | - | - | - | 1件: 6 6 💬
|
| 777 | Different diets | - | - | - | - | 1件: 6 6 💬
|
| 778 | DIGIPARK MONITOR | - | - | - | - | 1件: 6 6 💬
|
| 779 | Dihydroergot mesylate | - | - | - | - | 1件: 6 6 💬
|
| 780 | Dihydroergotine mesylate sustained-release tablets | - | - | - | - | 1件: 6 6 💬
|
| 781 | Dihydroergotoxine | 1件: Dihydroergotoxine Dihydroergotoxine | 1件: Dihydroergotoxine
Dihydroergotoxine
💬
| - | - | 1件: 6 6 💬
|
| 782 | Dipivefrin | 1件: Dipivefrin Dipivefrin | 2件: Dipivefrin hydrochloride
Dipivefrin hydrochloride
,
Dipivefrin
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 783 | Dipraglurant | 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 💬
|
| 784 | Ditropan elixir | - | - | - | - | 1件: 6 6 💬
|
| 785 | DM-1992 | - | - | - | - | 1件: 6 6 💬
|
| 786 | DNL151 | - | - | - | - | 1件: 6 6 💬
|
| 787 | DNL151, DN0001575, DN1575 | - | - | - | - | 1件: 6 6 💬
|
| 788 | DNL201 | - | - | - | - | 1件: 6 6 💬
|
| 789 | DNS-7801 (high dose) | - | - | - | - | 1件: 6 6 💬
|
| 790 | DNS-7801 (low-dose) | - | - | - | - | 1件: 6 6 💬
|
| 791 | Docosahexaenoic Acid (DHA) | - | - | - | - | 3件: 6 6, 94, 299 💬
|
| 792 | Domperidone | 1件: Domperidone Domperidone | 2件: Domperidone
Domperidone
,
Domperidone maleate
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 💬
|
| 793 | Domperidone (drug) | 1件: Domperidone Domperidone | 2件: Domperidone
Domperidone
,
Domperidone maleate
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 794 | Dompéridone | - | - | - | - | 1件: 6 6 💬
|
| 795 | Donepezil | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 8件: 5 5, 6, 13, 46, 124, 127, 156, 206 💬
|
| 796 | Donepezil (Aricept) | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 797 | Donepezil Hydrochloride | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 124, 156 💬
|
| 798 | Donepezil Sandoz | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 799 | Dopacell | - | - | - | - | 1件: 6 6 💬
|
| 800 | DopaFuse Delivery System | - | - | - | - | 1件: 6 6 💬
|
| 801 | Dopamine | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 7, 17, 74, 77 💬
|
| 802 | Dopamine Agent | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 803 | Dopamine Agonists (pramipexole, ropirinole) | 2件: Dopamine Dopamine, Pramipexole | 4件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Dopamine hydrochloride
,
Pramipexole
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 804 | Dopaminergic Agonist + Apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 805 | Dopaminergic Agonists | - | - | - | - | 1件: 6 6 💬
|
| 806 | Dopaminergic medication | - | - | - | - | 1件: 6 6 💬
|
| 807 | Doxepin | 1件: Doxepin Doxepin | 2件: Doxepin hydrochloride
Doxepin hydrochloride
,
Doxepin
💬
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 808 | Doxepin and Zopiclone | 2件: Doxepin Doxepin, Zopiclone | 3件: Doxepin hydrochloride
Doxepin hydrochloride
,
Zopiclone
,
Doxepin
💬
| 19件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬
| 12件: Cadherin signaling Cadherin signaling, Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬 | 1件: 6 6 💬
|
| 809 | DPA-714 Metabolite Analysis | - | - | - | - | 1件: 6 6 💬
|
| 810 | DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 💬
|
| 811 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 💬
|
| 812 | Droxidopa 100 MG [Northera] | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 813 | DSP-9632P 27.5 mg | - | - | - | - | 1件: 6 6 💬
|
| 814 | DSP-9632P 55.0 mg | - | - | - | - | 1件: 6 6 💬
|
| 815 | DSP-9632P 82.5 mg | - | - | - | - | 1件: 6 6 💬
|
| 816 | Duloxetine | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 97 💬
|
| 817 | Duloxetine hydrochloride | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 818 | DUODOPA | - | - | - | - | 1件: 6 6 💬
|
| 819 | Duodopa gel intestinale | - | - | - | - | 1件: 6 6 💬
|
| 820 | Duodopa intestinal gel | - | - | - | - | 1件: 6 6 💬
|
| 821 | Duodopa intestinalgel | - | - | - | - | 1件: 6 6 💬
|
| 822 | Duodopa LD/CD 20/5 mg/mL | - | - | - | - | 1件: 6 6 💬
|
| 823 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | - | - | - | - | 1件: 6 6 💬
|
| 824 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 825 | DUODOPA®Intestinal Gel | - | - | - | - | 1件: 6 6 💬
|
| 826 | Dynacirc CR (Isradipine) | 1件: Isradipine Isradipine | 1件: Isradipine
Isradipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 827 | E2007 | - | - | - | - | 2件: 6 6, 144 💬
|
| 828 | E2027 | - | - | - | - | 1件: 6 6 💬
|
| 829 | EBIXA | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 830 | EBIXA® | - | - | - | - | 1件: 6 6 💬
|
| 831 | EC5026 oral tablet | - | - | - | - | 2件: 6 6, 70 💬
|
| 832 | EDARAVONE | 1件: Edaravone Edaravone | 1件: Edaravone
Edaravone
💬
| - | - | 3件: 2 2, 6, 22 💬
|
| 833 | ELC200 | - | - | - | - | 1件: 6 6 💬
|
| 834 | Electroacupuncture | - | - | - | - | 2件: 6 6, 70 💬
|
| 835 | Electrolyte Beverage | - | - | - | - | 1件: 6 6 💬
|
| 836 | Eliprodil | 1件: Eliprodil Eliprodil | - | - | - | 1件: 6 6 💬
|
| 837 | Elobixibat | 1件: Elobixibat Elobixibat | 1件: Elobixibat
Elobixibat
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 6 6 💬
|
| 838 | ELTOPRAZINE | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 💬
|
| 839 | Eltoprazine HCl | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 💬
|
| 840 | Eltoprazine Hydrochloride | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 💬
|
| 841 | Embryonic dopamine cell implant surgery | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 842 | EMD 128130 | - | - | - | - | 2件: 6 6, 156 💬
|
| 843 | EMD128130 | - | - | - | - | 1件: 6 6 💬
|
| 844 | EN | - | - | - | - | 1件: 6 6 💬
|
| 845 | ENA713 | - | - | - | - | 2件: 6 6, 13 💬
|
| 846 | ENA713B | - | - | - | - | 1件: 6 6 💬
|
| 847 | ENERGI-F705 Tablets | - | - | - | - | 1件: 6 6 💬
|
| 848 | EnFuse | - | - | - | - | 1件: 6 6 💬
|
| 849 | ENT-01 | - | - | - | - | 1件: 6 6 💬
|
| 850 | Entacapon | - | - | - | - | 1件: 6 6 💬
|
| 851 | ENTACAPONA | - | - | - | - | 1件: 6 6 💬
|
| 852 | ENTACAPONE | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 853 | Entacapone 400mg oral dose | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 854 | Entacapone and carbidopa | 2件: Carbidopa Carbidopa, Entacapone | 2件: Carbidopa
Carbidopa
,
Entacapone
💬
| 2件: COMT COMT, DDC 💬
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 855 | ENTACAPONE INN | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 856 | Entecapone | - | - | - | - | 1件: 6 6 💬
|
| 857 | EPI-589 | 1件: EPI-589 EPI-589 | - | - | - | 2件: 2 2, 6 💬
|
| 858 | EPI-743 200mg | - | - | - | - | 1件: 6 6 💬
|
| 859 | EPI-743 400mg | - | - | - | - | 1件: 6 6 💬
|
| 860 | Equfina | - | - | - | - | 1件: 6 6 💬
|
| 861 | Equfina 50 mg | - | - | - | - | 1件: 6 6 💬
|
| 862 | ER CD-LD | - | - | - | - | 1件: 6 6 💬
|
| 863 | ER tablet 100 mg AZD3241 | - | - | - | - | 1件: 6 6 💬
|
| 864 | ER tablet 25 mg AZD3241 | - | - | - | - | 1件: 6 6 💬
|
| 865 | Eradication of Helcobacter Pylori | - | - | - | - | 1件: 6 6 💬
|
| 866 | Eradication therapy for H.pylori infection | - | - | - | - | 1件: 6 6 💬
|
| 867 | Eradication therapy for Helicobacter pylori | - | - | - | - | 1件: 6 6 💬
|
| 868 | Eril® | - | - | - | - | 2件: 2 2, 6 💬
|
| 869 | Erythromycin | 1件: Erythromycin Erythromycin | 7件: Erythromycin
Erythromycin
,
Erythromycin estolate
,
Erythromycin ethylsuccinate
,
Erythromycin lactobionate
,
Erythromycin stearate
,
Erythromycin gluceptate
,
Erythromycin thiocyanate
💬
| - | - | 6件: 2 2, 6, 36, 164, 228, 291 💬
|
| 870 | ERYTHROPOIETIN | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 11件: 2 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
|
| 871 | Erythropoietin human recombinant (EPOrh) | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 6 6 💬
|
| 872 | Escitalopram | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 5件: 2 2, 6, 13, 46, 77 💬
|
| 873 | Escitalopram oxalate | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 874 | ESKETAMINE | 1件: Esketamine Esketamine | 2件: Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 4, 6, 70, 96, 97, 156 💬
|
| 875 | Esomeprazole | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 10件: 6 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
|
| 876 | Eszopiclone | 1件: Eszopiclone Eszopiclone | 1件: Eszopiclone
Eszopiclone
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 9件: Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 46 💬
|
| 877 | ETHNODYNE VISIO | - | - | - | - | 1件: 6 6 💬
|
| 878 | Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below) | - | - | - | - | 1件: 6 6 💬
|
| 879 | Etomidate | 1件: Etomidate Etomidate | 1件: Etomidate
Etomidate
💬
| 1件: GABRA1 GABRA1 💬
| 8件: Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | 2件: 6 6, 11 💬
|
| 880 | Etoricoxib | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 6 6, 46, 70, 165, 271 💬
|
| 881 | Evaluation of mathematical models | - | - | - | - | 1件: 6 6 💬
|
| 882 | Exablate MRgFUS subthalamotomy | - | - | - | - | 1件: 6 6 💬
|
| 883 | Exametazime | 1件: Exametazime Exametazime | 1件: Exametazime
Exametazime
💬
| - | - | 1件: 6 6 💬
|
| 884 | EXELON | - | - | - | - | 2件: 6 6, 13 💬
|
| 885 | Exelon 4.6 mg/24 h transdermal patch | - | - | - | - | 1件: 6 6 💬
|
| 886 | Exelon 9.5 mg/24 h transdermal patch | - | - | - | - | 1件: 6 6 💬
|
| 887 | Exelon Patch (rivastigmine transdermal system) | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 888 | Exelon path transdermal | - | - | - | - | 1件: 6 6 💬
|
| 889 | Exelon ® | - | - | - | - | 1件: 6 6 💬
|
| 890 | EXENATIDE | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 💬
|
| 891 | Exenatide 10 micrograms | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 892 | Exenatide 5 micrograms | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 893 | Exenatide extended release 2mg (Bydureon) | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 894 | Exergame | - | - | - | - | 2件: 6 6, 13 💬
|
| 895 | Exidavnemab | 1件: Exidavnemab Exidavnemab | - | - | - | 2件: 6 6, 17 💬
|
| 896 | EXN-32 | - | - | - | - | 1件: 6 6 💬
|
| 897 | EXN-32 (CARBIDOPA E LEVODOPA) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 898 | EXN-44 | - | - | - | - | 1件: 6 6 💬
|
| 899 | EXN-44(LEVODOPA) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 900 | Extended Release Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 901 | F-18 FPCIT | - | - | - | - | 1件: 6 6 💬
|
| 902 | Famotidine | 1件: Famotidine Famotidine | 1件: Famotidine
Famotidine
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 7件: 6 6, 46, 86, 98, 107, 145, 300 💬
|
| 903 | Fasting blood test | - | - | - | - | 1件: 6 6 💬
|
| 904 | Fasudil | 1件: Fasudil Fasudil | 2件: Fasudil hydrochloride
Fasudil hydrochloride
,
Fasudil
💬
| 2件: ROCK1 ROCK1, ROCK2 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 2 2, 5, 6, 7, 51 💬
|
| 905 | FASUDIL HYDROCHLORIDE | 1件: Fasudil Fasudil | 2件: Fasudil hydrochloride
Fasudil hydrochloride
,
Fasudil
💬
| 2件: ROCK1 ROCK1, ROCK2 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 6 💬
|
| 906 | FB-101 | 1件: FB-101 FB-101 | - | - | - | 1件: 6 6 💬
|
| 907 | FB418 | - | - | - | - | 2件: 2 2, 6 💬
|
| 908 | Febuxostat | 1件: Febuxostat Febuxostat | 2件: Febuxostat
Febuxostat
,
Febuxostat hydrate
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 5件: 2 2, 6, 13, 67, 97 💬
|
| 909 | Fecal microbial transplantation | - | - | - | - | 3件: 6 6, 96, 97 💬
|
| 910 | Fecal microbiota | 1件: Fecal microbiota Fecal microbiota | - | - | - | 14件: 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 911 | Fecal Microbiota Transfer provided by Human Biome Institute | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 6 6 💬
|
| 912 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 9件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
|
| 913 | Ferriprox 500 mg | - | - | - | - | 1件: 6 6 💬
|
| 914 | Ferrprox (Deferiprone) | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 915 | Fesoterodine | 1件: Fesoterodine Fesoterodine | 2件: Fesoterodine
Fesoterodine
,
Fesoterodine fumarate
💬
| 2件: CHRM2 CHRM2, CHRM3 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 916 | Fetal porcine cells, Neurocell-PD | 1件: NeuroCell-PD NeuroCell-PD | - | - | - | 1件: 6 6 💬
|
| 917 | Fexofenadine | 1件: Fexofenadine Fexofenadine | 2件: Fexofenadine hydrochloride
Fexofenadine hydrochloride
,
Fexofenadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 4件: 6 6, 13, 19, 46 💬
|
| 918 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 30件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 919 | Finamine tablets | - | - | - | - | 1件: 6 6 💬
|
| 920 | Finasteride | 1件: Finasteride Finasteride | 1件: Finasteride
Finasteride
💬
| 1件: SRD5A2 SRD5A2 💬
| 2件: Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 💬
|
| 921 | Fipamezole | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 922 | Fipamezole hydrochloride | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 923 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 924 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 925 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 926 | Fipamezole ODT | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬
|
| 927 | Fipamezole ODT Cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬
|
| 928 | Flecainide | 1件: Flecainide Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 2件: 6 6, 115 💬
|
| 929 | FLECAINIDE ACETATE | 2件: Acetate Acetate, Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 1件: 6 6 💬
|
| 930 | Flecainidum | 1件: Flecainide Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 1件: 6 6 💬
|
| 931 | FLORBETABEN (18F) | - | - | - | - | 1件: 6 6 💬
|
| 932 | Florbetapir F 18 | - | - | - | - | 1件: 6 6 💬
|
| 933 | Fludrocortisone | 1件: Fludrocortisone Fludrocortisone | 2件: Fludrocortisone acetate
Fludrocortisone acetate
,
Fludrocortisone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 💬
|
| 934 | Fluid biopsy capsule | - | - | - | - | 1件: 6 6 💬
|
| 935 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: Flumazenil
Flumazenil
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 9件: Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 💬
|
| 936 | Fluoroscopic swallow evaluation | - | - | - | - | 1件: 6 6 💬
|
| 937 | Flutemetamol | 1件: Flutemetamol Flutemetamol | - | - | - | 6件: 2 2, 5, 6, 7, 17, 127 💬
|
| 938 | Folic acid | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 9件: 6 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
|
| 939 | Folic Acid 1 MG | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
| 940 | Folic Acid Tablet | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
| 941 | Folic Acid, Vitamin B6, Vitamin B12 | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
| 942 | Foliglurax | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 💬
|
| 943 | Foliglurax 10 mg (treatment A) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 💬
|
| 944 | Foliglurax 30 mg (treatment B) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 💬
|
| 945 | Fortiral | - | - | - | - | 1件: 6 6 💬
|
| 946 | Foscarbidopa | 1件: Foscarbidopa Foscarbidopa | 1件: Foscarbidopa
Foscarbidopa
💬
| - | - | 1件: 6 6 💬
|
| 947 | Foscarbidopa and Foslevodopa | 2件: Foscarbidopa Foscarbidopa, Foslevodopa | 2件: Foslevodopa
Foslevodopa
,
Foscarbidopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 948 | Foslevodopa | 1件: Foslevodopa Foslevodopa | 1件: Foslevodopa
Foslevodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 949 | FPFS-1169 | - | - | - | - | 1件: 6 6 💬
|
| 950 | Full-spectrum Cannabidiol (CBD) oil | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 951 | Functional Magnetic Resonance Imaging | - | - | - | - | 1件: 6 6 💬
|
| 952 | Furosemide | 1件: Furosemide Furosemide | 1件: Furosemide
Furosemide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 5件: 6 6, 57, 77, 86, 222 💬
|
| 953 | Furosemide Injection | 1件: Furosemide Furosemide | 1件: Furosemide
Furosemide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 222 💬
|
| 954 | Fursultiamine | 1件: Fursultiamine Fursultiamine | 2件: Fursultiamine
Fursultiamine
,
Fursultiamine hydrochloride
💬
| - | - | 2件: 6 6, 18 💬
|
| 955 | G-CSF | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 12件: 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 956 | GABAPENTIN | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 7件: 6 6, 13, 18, 19, 70, 226, 298 💬
|
| 957 | GABAPENTINA | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 958 | GABAPENTINA KERN PHARMA | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 959 | GALANTAMINE | 1件: Galantamine Galantamine | 2件: Galantamine hydrobromide
Galantamine hydrobromide
,
Galantamine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 11, 127 💬
|
| 960 | Galantamine HBr extended-release 8mg capsules (8mg ER). | 1件: Galantamine Galantamine | 2件: Galantamine hydrobromide
Galantamine hydrobromide
,
Galantamine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 961 | Galantamine hydrobromide | 1件: Galantamine Galantamine | 2件: Galantamine hydrobromide
Galantamine hydrobromide
,
Galantamine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 2件: 6 6, 127 💬
|
| 962 | Gamma- glutamylcysteine | - | - | - | - | 1件: 6 6 💬
|
| 963 | Ganoderma | - | - | - | - | 1件: 6 6 💬
|
| 964 | GE180 PET Scan | - | - | - | - | 1件: 6 6 💬
|
| 965 | Gemfibrozil | 1件: Gemfibrozil Gemfibrozil | 1件: Gemfibrozil
Gemfibrozil
💬
| 1件: PPARA PPARA 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
| 966 | Gene therapy | - | - | - | - | 2件: 6 6, 19 💬
|
| 967 | General anesthesia | - | - | - | - | 1件: 6 6 💬
|
| 968 | Genetic: AAV-GAD | - | - | - | - | 1件: 6 6 💬
|
| 969 | Genetic: AAV-GAD High Dose | - | - | - | - | 1件: 6 6 💬
|
| 970 | Genetic: AAV-GAD Low Dose | - | - | - | - | 1件: 6 6 💬
|
| 971 | Genetic: AAV-hAADC-2 | - | - | - | - | 1件: 6 6 💬
|
| 972 | Genetic: Adipose-derived stromal vascular fraction cells | - | - | - | - | 1件: 6 6 💬
|
| 973 | Genetic: APOE genotype | - | - | - | - | 1件: 6 6 💬
|
| 974 | Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus | - | - | - | - | 1件: 6 6 💬
|
| 975 | Genetic: biomarker identification in Parkinson disease | - | - | - | - | 1件: 6 6 💬
|
| 976 | Genetic: blood draw | - | - | - | - | 1件: 6 6 💬
|
| 977 | Genetic: Blood Sampling and DNA collection | - | - | - | - | 1件: 6 6 💬
|
| 978 | Genetic: CERE-120: AAV2-NTN | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
| 979 | Genetic: Cohort1 | - | - | - | - | 1件: 6 6 💬
|
| 980 | Genetic: Cohort2 | - | - | - | - | 1件: 6 6 💬
|
| 981 | Genetic: Convection enhanced delivery/AAV2-GDNF | - | - | - | - | 1件: 6 6 💬
|
| 982 | Genetic: DNA Analysis | - | - | - | - | 3件: 6 6, 28, 60 💬
|
| 983 | Genetic: DNA/GeneticTesting | - | - | - | - | 1件: 6 6 💬
|
| 984 | Genetic: G2019S LRRK2 | - | - | - | - | 1件: 6 6 💬
|
| 985 | Genetic: gene therapy | - | - | - | - | 1件: 6 6 💬
|
| 986 | Genetic: Genetic: whole genome sequencing | - | - | - | - | 3件: 2 2, 6, 127 💬
|
| 987 | Genetic: Healthy | - | - | - | - | 1件: 6 6 💬
|
| 988 | Genetic: Identification of COMT HH, COMT HL or COMT LL genes | - | - | - | - | 1件: 6 6 💬
|
| 989 | Genetic: Injecting BBM-P002 into the bilateral putamen | - | - | - | - | 1件: 6 6 💬
|
| 990 | Genetic: KL002 injection solution | - | - | - | - | 1件: 6 6 💬
|
| 991 | Genetic: Non intervention-Genetic testing | - | - | - | - | 1件: 6 6 💬
|
| 992 | Genetic: Optional pharmacogenetic assessment | - | - | - | - | 1件: 6 6 💬
|
| 993 | Genetic: PKD Patients | - | - | - | - | 1件: 6 6 💬
|
| 994 | Genetic: SHMT1 polymorphism | - | - | - | - | 1件: 6 6 💬
|
| 995 | Genetic: Skin biopsy | - | - | - | - | 1件: 6 6 💬
|
| 996 | Genetic: Surgical infusion of AAV-GAD into the subthalamic nucleus | - | - | - | - | 1件: 6 6 💬
|
| 997 | Genetic: whole exome sequencing | - | - | - | - | 6件: 2 2, 6, 65, 120, 127, 149 💬
|
| 998 | Genetic: whole genome sequencing | - | - | - | - | 3件: 6 6, 79, 172 💬
|
| 999 | Genz-682452-AU | - | - | - | - | 3件: 6 6, 19, 67 💬
|
| 1000 | Glial cell line-derived neurotrophic factor | - | - | - | - | 1件: 6 6 💬
|
| 1001 | Glial Cell Line-Derived Neurotrophic Factor (GDNF) | - | - | - | - | 1件: 6 6 💬
|
| 1002 | Glucose | - | - | - | - | 3件: 6 6, 13, 299 💬
|
| 1003 | Glutathione | 1件: Glutathione Glutathione | 1件: Glutathione
Glutathione
💬
| - | - | 2件: 6 6, 299 💬
|
| 1004 | Glycerol Phenylbutyrate | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: Glycerol phenylbutyrate
Glycerol phenylbutyrate
💬
| - | - | 2件: 6 6, 7 💬
|
| 1005 | Glycopyrrolate | - | - | - | - | 2件: 6 6, 34 💬
|
| 1006 | GM1 | - | - | - | - | 1件: 6 6 💬
|
| 1007 | GM1 ganglioside | - | - | - | - | 1件: 6 6 💬
|
| 1008 | GM101 | - | - | - | - | 1件: 6 6 💬
|
| 1009 | GM608 | - | - | - | - | 1件: 6 6 💬
|
| 1010 | GOCOVRI | - | - | - | - | 1件: 6 6 💬
|
| 1011 | Gold | 1件: Gold Gold | - | - | - | 71件: 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 1012 | Gold Nanocrystals | 1件: Gold Gold | - | - | - | 3件: 2 2, 6, 13 💬
|
| 1013 | GPI 1485 | - | - | - | - | 1件: 6 6 💬
|
| 1014 | Grapefruit | 1件: Grapefruit Grapefruit | - | - | - | 5件: 6 6, 46, 50, 83, 97 💬
|
| 1015 | Green Tea Polyphenols (EGCG/ECG) | - | - | - | - | 1件: 6 6 💬
|
| 1016 | GRF6021 | - | - | - | - | 1件: 6 6 💬
|
| 1017 | Group AD Anti-PD + Antidepressant | - | - | - | - | 1件: 6 6 💬
|
| 1018 | Group R Rasagiline | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAOB MAOB 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1019 | Group R+AD Rasagiline + Antidepressant | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAOB MAOB 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1020 | GSK962040 | - | - | - | - | 1件: 6 6 💬
|
| 1021 | GSK962040 (25 mg tablet) | - | - | - | - | 1件: 6 6 💬
|
| 1022 | GT-02287 | - | - | - | - | 1件: 6 6 💬
|
| 1023 | Guar gum | 1件: Guar gum Guar gum | 1件: Guar gum
Guar gum
💬
| - | - | 1件: 6 6 💬
|
| 1024 | HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM | - | - | - | - | 2件: 6 6, 49 💬
|
| 1025 | HAESCs | - | - | - | - | 1件: 6 6 💬
|
| 1026 | HAESCs treatment | - | - | - | - | 1件: 6 6 💬
|
| 1027 | HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells) | - | - | - | - | 1件: 6 6 💬
|
| 1028 | HB-adMSCs | - | - | - | - | 8件: 2 2, 4, 6, 13, 14, 46, 49, 113 💬
|
| 1029 | HBI-002 | - | - | - | - | 1件: 6 6 💬
|
| 1030 | Healthy donor-derived FMT capsule | - | - | - | - | 1件: 6 6 💬
|
| 1031 | HEC122505MsOH | - | - | - | - | 1件: 6 6 💬
|
| 1032 | Helicobacter pylori eradication therapy | - | - | - | - | 1件: 6 6 💬
|
| 1033 | Hemoglobin | 1件: Hemoglobin Hemoglobin | - | - | - | 3件: 6 6, 60, 283 💬
|
| 1034 | Heptaminol | 1件: Heptaminol Heptaminol | 2件: Heptaminol
Heptaminol
,
Heptaminol hydrochloride
💬
| - | - | 1件: 6 6 💬
|
| 1035 | Heptaminol hydrochloride | 1件: Heptaminol Heptaminol | 2件: Heptaminol
Heptaminol
,
Heptaminol hydrochloride
💬
| - | - | 1件: 6 6 💬
|
| 1036 | HER-096 | - | - | - | - | 1件: 6 6 💬
|
| 1037 | Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.) | - | - | - | - | 1件: 6 6 💬
|
| 1038 | Hericium erinaceus mycelium | - | - | - | - | 1件: 6 6 💬
|
| 1039 | HF0220 | - | - | - | - | 1件: 6 6 💬
|
| 1040 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 💬
|
| 1041 | High dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 💬
|
| 1042 | High Dose GT-02287 | - | - | - | - | 1件: 6 6 💬
|
| 1043 | High dose levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1044 | High Fiber supplement | - | - | - | - | 1件: 6 6 💬
|
| 1045 | High Protein. T-Diet plus Range | - | - | - | - | 1件: 6 6 💬
|
| 1046 | High-Frequency-Only Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 1047 | HL-400 | - | - | - | - | 1件: 6 6 💬
|
| 1048 | HNC364 | - | - | - | - | 1件: 6 6 💬
|
| 1049 | HNC364 Injectable Suspension | - | - | - | - | 1件: 6 6 💬
|
| 1050 | Home based balance training | - | - | - | - | 2件: 6 6, 13 💬
|
| 1051 | HOV-12020 | 1件: HOV-12020 HOV-12020 | - | - | - | 2件: 6 6, 124 💬
|
| 1052 | HRG2010 | - | - | - | - | 1件: 6 6 💬
|
| 1053 | HRG2010 Capsule, Sinemet®, Madopar® | - | - | - | - | 1件: 6 6 💬
|
| 1054 | HRG2010(I) | - | - | - | - | 1件: 6 6 💬
|
| 1055 | HRG2010(II) | - | - | - | - | 1件: 6 6 💬
|
| 1056 | HUC-MSC-sEV-001 nasal drops | - | - | - | - | 3件: 2 2, 6, 17 💬
|
| 1057 | Human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection | - | - | - | - | 1件: 6 6 💬
|
| 1058 | Human Amniotic Epithelial Stem Cells | - | - | - | - | 1件: 6 6 💬
|
| 1059 | Human Dopaminergic Progenitor Cells | - | - | - | - | 2件: 6 6, 17 💬
|
| 1060 | Human neural stem cell | - | - | - | - | 1件: 6 6 💬
|
| 1061 | Human Stem Cells | - | - | - | - | 1件: 6 6 💬
|
| 1062 | Human-derived stromal cells | - | - | - | - | 1件: 6 6 💬
|
| 1063 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
|
| 1064 | Hydrocortisone cream | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1065 | Hydrocortisone cream 1% | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1066 | Hydrocortisone cream 10mg/g FNA Fagron | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1067 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 8件: 5 5, 6, 13, 17, 83, 97, 226, 238 💬
|
| 1068 | Hydrolyzed guar gum | 1件: Guar gum Guar gum | 1件: Guar gum
Guar gum
💬
| - | - | 1件: 6 6 💬
|
| 1069 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 29件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 1070 | Hydroxychloroquine (HCQ) | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 2件: 6 6, 53 💬
|
| 1071 | Hypoestoxide | - | - | - | - | 1件: 6 6 💬
|
| 1072 | Hypoxic Gas Mixture | - | - | - | - | 1件: 6 6 💬
|
| 1073 | I-123-5-IA85380 | - | - | - | - | 1件: 6 6 💬
|
| 1074 | IBEROGAST | - | - | - | - | 1件: 6 6 💬
|
| 1075 | ICA07 therapy | - | - | - | - | 1件: 6 6 💬
|
| 1076 | Idebenone | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 9件: 6 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
|
| 1077 | IkT-148009 | - | - | - | - | 1件: 6 6 💬
|
| 1078 | Iloperidone | 1件: Iloperidone Iloperidone | 1件: Iloperidone
Iloperidone
💬
| 4件: DRD2 DRD2, HTR2A, HTR2B, HTR2C 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1079 | Immediate release carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1080 | Immediate Release carbidopa/levodopa 10/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1081 | Immediate Release carbidopa/levodopa 25/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1082 | Immediate Release Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1083 | Immunosuppressive Regimen | - | - | - | - | 1件: 6 6 💬
|
| 1084 | Incobotulinum Toxin A | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 1085 | IncobotulinumtoxinA | - | - | - | - | 1件: 6 6 💬
|
| 1086 | IncobotulinumtoxinA (100 Units) | - | - | - | - | 1件: 6 6 💬
|
| 1087 | IncobotulinumtoxinA (75 Units) | - | - | - | - | 1件: 6 6 💬
|
| 1088 | Infudopa i.v. | - | - | - | - | 1件: 6 6 💬
|
| 1089 | Infudopa s.c. | - | - | - | - | 1件: 6 6 💬
|
| 1090 | Infusion Pump: CADD-Legacy® 1400 Pump | - | - | - | - | 1件: 6 6 💬
|
| 1091 | Infusions of young plasma | - | - | - | - | 1件: 6 6 💬
|
| 1092 | Inhaled VR040 | - | - | - | - | 1件: 6 6 💬
|
| 1093 | Injection | - | - | - | - | 2件: 6 6, 301 💬
|
| 1094 | Injection of apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1095 | Injection of normal saline | - | - | - | - | 1件: 6 6 💬
|
| 1096 | Injection of Umbilical cord derived MSCs | - | - | - | - | 1件: 6 6 💬
|
| 1097 | INN not available at this time | - | - | - | - | 1件: 6 6 💬
|
| 1098 | Inosine | 1件: Inosine Inosine | 1件: Inosine
Inosine
💬
| - | - | 5件: 2 2, 6, 13, 17, 122 💬
|
| 1099 | INS-GSH | - | - | - | - | 1件: 6 6 💬
|
| 1100 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 77, 299 💬
|
| 1101 | Intervention: Ketamine | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1102 | Intracerebral microinjections | - | - | - | - | 1件: 6 6 💬
|
| 1103 | Intranasal glutathione - (in)GSH | 1件: Glutathione Glutathione | 1件: Glutathione
Glutathione
💬
| - | - | 1件: 6 6 💬
|
| 1104 | Intranasal Insulin | - | - | - | - | 2件: 6 6, 17 💬
|
| 1105 | Intrathecal (IT) | - | - | - | - | 1件: 6 6 💬
|
| 1106 | Intravenous | - | - | - | - | 1件: 6 6 💬
|
| 1107 | Intravenous Infusion | - | - | - | - | 3件: 6 6, 18, 51 💬
|
| 1108 | Intravenous Levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1109 | Intravesical injection of Botulinum A toxin | - | - | - | - | 2件: 6 6, 17 💬
|
| 1110 | Inulin | 1件: Inulin Inulin | 1件: Inulin
Inulin
💬
| - | - | 5件: 6 6, 96, 97, 156, 299 💬
|
| 1111 | Inulin, B-vitamins and vitamin D | 2件: Inulin Inulin, Vitamin D | 1件: Inulin
Inulin
💬
| - | - | 1件: 6 6 💬
|
| 1112 | IODIO IOFLUPANO-123I | - | - | - | - | 1件: 6 6 💬
|
| 1113 | Ioflupane | - | - | - | - | 1件: 6 6 💬
|
| 1114 | IOFLUPANE (123I) | - | - | - | - | 1件: 6 6 💬
|
| 1115 | Ioflupane 123I (DATSCAN®) | - | - | - | - | 1件: 6 6 💬
|
| 1116 | Ioflupane [123 I] | - | - | - | - | 1件: 6 6 💬
|
| 1117 | Ioflupane [123I] | - | - | - | - | 1件: 6 6 💬
|
| 1118 | Ioflupane I 123 | - | - | - | - | 1件: 6 6 💬
|
| 1119 | Ipratropium | 1件: Ipratropium Ipratropium | - | - | - | 2件: 6 6, 86 💬
|
| 1120 | Ipratropium bromide (drug) | 1件: Ipratropium Ipratropium | - | - | - | 1件: 6 6 💬
|
| 1121 | IPRONIAZID | 1件: Iproniazid Iproniazid | 2件: Iproniazid
Iproniazid
,
Iproniazid phosphate
💬
| 2件: MAOA MAOA, MAOB 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1122 | Ips-nsc cells | - | - | - | - | 1件: 6 6 💬
|
| 1123 | IPS101A | - | - | - | - | 1件: 6 6 💬
|
| 1124 | IPT803 | - | - | - | - | 1件: 6 6 💬
|
| 1125 | IPX054 100 mg | - | - | - | - | 1件: 6 6 💬
|
| 1126 | IPX054 150 mg | - | - | - | - | 1件: 6 6 💬
|
| 1127 | IPX054 200 mg | - | - | - | - | 1件: 6 6 💬
|
| 1128 | IPX054 250 mg | - | - | - | - | 1件: 6 6 💬
|
| 1129 | IPX054 300 mg | - | - | - | - | 1件: 6 6 💬
|
| 1130 | IPX066 | - | - | - | - | 1件: 6 6 💬
|
| 1131 | IPX066 145 mg | - | - | - | - | 1件: 6 6 💬
|
| 1132 | IPX066 145 mg LD | - | - | - | - | 1件: 6 6 💬
|
| 1133 | IPX066 195 mg | - | - | - | - | 1件: 6 6 💬
|
| 1134 | IPX066 195 mg LD | - | - | - | - | 1件: 6 6 💬
|
| 1135 | IPX066 245 mg | - | - | - | - | 1件: 6 6 💬
|
| 1136 | IPX066 245 mg LD | - | - | - | - | 1件: 6 6 💬
|
| 1137 | IPX066 95 mg | - | - | - | - | 1件: 6 6 💬
|
| 1138 | IPX066 95 mg LD | - | - | - | - | 1件: 6 6 💬
|
| 1139 | IPX066-145 | - | - | - | - | 1件: 6 6 💬
|
| 1140 | IPX066-195 | - | - | - | - | 1件: 6 6 💬
|
| 1141 | IPX066-245 | - | - | - | - | 1件: 6 6 💬
|
| 1142 | IPX066-95 | - | - | - | - | 1件: 6 6 💬
|
| 1143 | IPX203 | - | - | - | - | 1件: 6 6 💬
|
| 1144 | IPX203 140 mg | - | - | - | - | 1件: 6 6 💬
|
| 1145 | IPX203 180 mg | - | - | - | - | 1件: 6 6 💬
|
| 1146 | IPX203 210 mg | - | - | - | - | 1件: 6 6 💬
|
| 1147 | IPX203 270 mg | - | - | - | - | 1件: 6 6 💬
|
| 1148 | IPX203 280 mg | - | - | - | - | 1件: 6 6 💬
|
| 1149 | IPX203 350 mg | - | - | - | - | 1件: 6 6 💬
|
| 1150 | IPX203 ER CD-LD | - | - | - | - | 1件: 6 6 💬
|
| 1151 | IR CD-LD | - | - | - | - | 1件: 6 6 💬
|
| 1152 | IR CD-LD (carbidopa-levodopa) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1153 | IR LD / CD | - | - | - | - | 1件: 6 6 💬
|
| 1154 | IR LD/CD | - | - | - | - | 1件: 6 6 💬
|
| 1155 | IRBD | - | - | - | - | 1件: 6 6 💬
|
| 1156 | IRL752 | - | - | - | - | 1件: 6 6 💬
|
| 1157 | IRL757 | - | - | - | - | 1件: 6 6 💬
|
| 1158 | IRL790 | - | - | - | - | 1件: 6 6 💬
|
| 1159 | IRX4204 | - | - | - | - | 1件: 6 6 💬
|
| 1160 | ISC-hpNSC | - | - | - | - | 1件: 6 6 💬
|
| 1161 | Isicom | - | - | - | - | 1件: 6 6 💬
|
| 1162 | Isoflurane | 1件: Isoflurane Isoflurane | 1件: Isoflurane
Isoflurane
💬
| - | - | 1件: 6 6 💬
|
| 1163 | Isradipine | 1件: Isradipine Isradipine | 1件: Isradipine
Isradipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1164 | Isradipine CR 10mg | 1件: Isradipine Isradipine | 1件: Isradipine
Isradipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1165 | Isradipine CR 20mg | 1件: Isradipine Isradipine | 1件: Isradipine
Isradipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1166 | Isradipine CR 5mg | 1件: Isradipine Isradipine | 1件: Isradipine
Isradipine
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1167 | ISTRADEFYLLINE | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1168 | Istradefylline ( KW-6002) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1169 | Istradefylline (KW-6002) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1170 | Istradefylline 20 mg | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1171 | Istradefylline 20 mg or 40 mg | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1172 | Istradefylline 40 mg | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1173 | Istradefylline medication | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1174 | Istradefylline Pill | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1175 | ITI-214 | - | - | - | - | 1件: 6 6 💬
|
| 1176 | Itraconazole | 1件: Itraconazole Itraconazole | 1件: Itraconazole
Itraconazole
💬
| - | - | 13件: 2 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
|
| 1177 | IV Apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1178 | IV Levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1179 | IZD174 | - | - | - | - | 2件: 6 6, 106 💬
|
| 1180 | J-tube | - | - | - | - | 1件: 6 6 💬
|
| 1181 | Jejunal extension tube | - | - | - | - | 1件: 6 6 💬
|
| 1182 | Jejunal extension tube (J-tube) | - | - | - | - | 1件: 6 6 💬
|
| 1183 | JM-010 | - | - | - | - | 1件: 6 6 💬
|
| 1184 | JM-010 group A | - | - | - | - | 1件: 6 6 💬
|
| 1185 | JM-010 group B | - | - | - | - | 1件: 6 6 💬
|
| 1186 | JNJ-31001074 | - | - | - | - | 1件: 6 6 💬
|
| 1187 | JNJ31-31001074 | - | - | - | - | 1件: 6 6 💬
|
| 1188 | JP 1730 | - | - | - | - | 1件: 6 6 💬
|
| 1189 | JP-1730/F01 | - | - | - | - | 2件: 6 6, 17 💬
|
| 1190 | JP-1730/F02 | - | - | - | - | 2件: 6 6, 17 💬
|
| 1191 | JP-1730/F03 | - | - | - | - | 2件: 6 6, 17 💬
|
| 1192 | Juvit D3 | - | - | - | - | 1件: 6 6 💬
|
| 1193 | JX2105 | - | - | - | - | 1件: 6 6 💬
|
| 1194 | JZP-110 | - | - | - | - | 1件: 6 6 💬
|
| 1195 | JZP385 | - | - | - | - | 1件: 6 6 💬
|
| 1196 | K0706 | - | - | - | - | 1件: 6 6 💬
|
| 1197 | KDT-3594 | 1件: KDT-3594 KDT-3594 | - | - | - | 1件: 6 6 💬
|
| 1198 | KETAMINE | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 💬
|
| 1199 | Ketamine hydrochloride | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1200 | Ketamine Infusion | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1201 | Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate | - | - | - | - | 1件: 6 6 💬
|
| 1202 | Ketone Ester Beverage | - | - | - | - | 1件: 6 6 💬
|
| 1203 | Ketone ester drink | - | - | - | - | 2件: 6 6, 344 💬
|
| 1204 | Ketone Ester Elite endurance Nutrition Drink | - | - | - | - | 1件: 6 6 💬
|
| 1205 | Kinetra and Soletra (neurostimulator, Medtronic) | - | - | - | - | 1件: 6 6 💬
|
| 1206 | Kinoquinone (proposed) | - | - | - | - | 1件: 6 6 💬
|
| 1207 | KM-819 | - | - | - | - | 2件: 6 6, 17 💬
|
| 1208 | KP405 | - | - | - | - | 1件: 6 6 💬
|
| 1209 | KW-6002 | - | - | - | - | 1件: 6 6 💬
|
| 1210 | KW-6002 (istradefylline) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1211 | KW-6356 | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1212 | KW-6356 High Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1213 | KW-6356 Low Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1214 | KW-6356 Middle Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1215 | KW-6356 X Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1216 | KW-6356 Y Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 💬
|
| 1217 | KW-6500 | - | - | - | - | 1件: 6 6 💬
|
| 1218 | L-123 Ioflupane | - | - | - | - | 1件: 6 6 💬
|
| 1219 | L-3-(3,4-Dihydroxyphenyl)alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 1件: 6 6 💬
|
| 1220 | L-DOPA | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1221 | L-Dopa/ MODOPAR | - | - | - | - | 1件: 6 6 💬
|
| 1222 | L-DOPA/DDCI | - | - | - | - | 1件: 6 6 💬
|
| 1223 | L-DOPS | - | - | - | - | 1件: 6 6 💬
|
| 1224 | L-tyrosine | 1件: Tyrosine Tyrosine | 1件: Tyrosine
Tyrosine
💬
| - | - | 2件: 6 6, 111 💬
|
| 1225 | Lactobacillus acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 1件: 6 6 💬
|
| 1226 | Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 1件: 6 6 💬
|
| 1227 | Lactobacillus casei | 1件: Lactobacillus casei Lactobacillus casei | 1件: Lactobacillus casei
Lactobacillus casei
💬
| - | - | 3件: 6 6, 97, 296 💬
|
| 1228 | Lactobacillus casei DG (Enterolactis duo®) | 1件: Lactobacillus casei Lactobacillus casei | 1件: Lactobacillus casei
Lactobacillus casei
💬
| - | - | 1件: 6 6 💬
|
| 1229 | Lactobacillus plantarum | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 3件: 6 6, 97, 156 💬
|
| 1230 | Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 💬
|
| 1231 | Lactose | 1件: Lactose Lactose | 2件: Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | 8件: 2 2, 6, 13, 21, 97, 107, 228, 310 💬
|
| 1232 | Lactulose | 1件: Lactulose Lactulose | 1件: Lactulose
Lactulose
💬
| - | - | 5件: 6 6, 13, 96, 97, 291 💬
|
| 1233 | LBT-3627 | - | - | - | - | 1件: 6 6 💬
|
| 1234 | LCIG | - | - | - | - | 1件: 6 6 💬
|
| 1235 | LCIG (Duodopa) | - | - | - | - | 1件: 6 6 💬
|
| 1236 | LD / BE | - | - | - | - | 1件: 6 6 💬
|
| 1237 | LD+DDCI | - | - | - | - | 1件: 6 6 💬
|
| 1238 | LD-DDCI | - | - | - | - | 1件: 6 6 💬
|
| 1239 | LD/CD | - | - | - | - | 1件: 6 6 💬
|
| 1240 | LD/CD SC solution | - | - | - | - | 1件: 6 6 💬
|
| 1241 | Lecanemab | 1件: Lecanemab Lecanemab | 1件: Lecanemab
Lecanemab
💬
| 1件: APP APP 💬
| 4件: Alzheimer disease Alzheimer disease, IgSF CAM signaling, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 1242 | LECIG (levodopa, carbidopa, entacapone intestinal gel) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1243 | Lemborexant | 1件: Lemborexant Lemborexant | 1件: Lemborexant
Lemborexant
💬
| 2件: HCRTR1 HCRTR1, HCRTR2 💬
| 2件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 127 💬
|
| 1244 | Lenrispodun | 1件: Lenrispodun Lenrispodun | 1件: Lenrispodun
Lenrispodun
💬
| 3件: PDE1A PDE1A, PDE1B, PDE1C 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Morphine addiction, Olfactory transduction, Purine metabolism, Renin secretion, Taste transduction 💬 | 1件: 6 6 💬
|
| 1245 | Leptin | 1件: Leptin Leptin | - | - | - | 2件: 6 6, 265 💬
|
| 1246 | Leucine | 1件: Leucine Leucine | 1件: Leucine
Leucine
💬
| - | - | 13件: 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 1247 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2A SV2A 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 7件: 2 2, 4, 6, 13, 34, 149, 307 💬
|
| 1248 | Levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 5 5, 6, 17, 90, 120, 140, 164, 201 💬
|
| 1249 | LEVODOPA (DC.IT) (FU) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1250 | Levodopa (delivered intravenously) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1251 | Levodopa (drug), intraduodenal administration | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1252 | Levodopa (L-dopa) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1253 | Levodopa (L-DOPA) + Standard care | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1254 | LEVODOPA (LD) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1255 | Levodopa / Benserazid | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1256 | LEVODOPA / BENSERAZIDE 200 + 50 MG | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1257 | Levodopa / carbidopa solution | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1258 | Levodopa 100 mg / benserazide 25 mg | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1259 | Levodopa 100 mg A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1260 | Levodopa 125 mg A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1261 | Levodopa 150 mg A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1262 | Levodopa 75 mg A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1263 | Levodopa acute challenge | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1264 | Levodopa and carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1265 | Levodopa and decarboxylase inhibitor | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1266 | Levodopa and Domperidone | 2件: Domperidone Domperidone, Levodopa | 3件: Levodopa
Levodopa
,
Domperidone
,
Domperidone maleate
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1267 | Levodopa Benserazide Madopar | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1268 | Levodopa Benserazide Teva Italia | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1269 | Levodopa Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1270 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1271 | Levodopa carbidopa intestinal gel (LCIG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1272 | Levodopa CR (controlled release) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1273 | Levodopa Cyclops | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1274 | LEVODOPA DC.IT FU | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1275 | Levodopa dispersible | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1276 | Levodopa formulation | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1277 | Levodopa infusion | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1278 | LEVODOPA INN | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1279 | Levodopa MR | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1280 | Levodopa powder for inhalation | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1281 | Levodopa tablet | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1282 | Levodopa, carbidopa, entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1283 | Levodopa, carbidopa, ODM-104 | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1284 | Levodopa, decarboxylase inhibitor and COMT inhibitor | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1285 | Levodopa-4'-Monophosphate | 2件: Foslevodopa Foslevodopa, Levodopa | 2件: Levodopa
Levodopa
,
Foslevodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1286 | Levodopa-Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 90 💬
|
| 1287 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1288 | Levodopa-Carbidopa Immediate Release | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1289 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1290 | Levodopa-Carbidopa Intestinal Gel | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1291 | Levodopa-Carbidopa Intestinal Gel (LCIG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1292 | Levodopa-Carbidopa Multilayer Extended Release Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1293 | Levodopa-Carbidopa XL tablet (M) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1294 | Levodopa-carbidopa-entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1295 | Levodopa/benserazide | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1296 | Levodopa/benserazide 100/25 mg | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1297 | LEVODOPA/BENZERASIDE | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1298 | Levodopa/Benzerazide | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1299 | LEVODOPA/CARBIDOPA | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 164 💬
|
| 1300 | Levodopa/Carbidopa (LD/CD) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1301 | Levodopa/Carbidopa (Sinemet) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1302 | Levodopa/carbidopa 100/25 | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1303 | Levodopa/carbidopa oral formulation A | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1304 | Levodopa/carbidopa oral formulation B | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1305 | Levodopa/Carbidopa Solution | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1306 | Levodopa/carbidopa solution for SC administration | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1307 | Levodopa/Carbidopa(200mg/50mg) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1308 | Levodopa/carbidopa/entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1309 | Levodopa/DDCI | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1310 | Levodopa/dopa decarboxylase inhibitor | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1311 | Liatermin | 1件: Liatermin Liatermin | 1件: Liatermin
Liatermin
💬
| - | - | 1件: 6 6 💬
|
| 1312 | Liatermin (r-metHuGDNF) | 1件: Liatermin Liatermin | 1件: Liatermin
Liatermin
💬
| - | - | 1件: 6 6 💬
|
| 1313 | Lidocaine | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
| 1314 | Lidocaine hydrochloride | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 1件: 6 6 💬
|
| 1315 | Light box ( Litebook company) | - | - | - | - | 1件: 6 6 💬
|
| 1316 | Light box (Litebook company) | - | - | - | - | 1件: 6 6 💬
|
| 1317 | Linaclotide | 1件: Linaclotide Linaclotide | 2件: Linaclotide acetate
Linaclotide acetate
,
Linaclotide
💬
| 1件: GUCY2C GUCY2C 💬
| 2件: Hormone signaling Hormone signaling, Purine metabolism 💬 | 3件: 6 6, 97, 299 💬
|
| 1318 | Lingzhi (Ganoderma) | - | - | - | - | 1件: 6 6 💬
|
| 1319 | Lipopolysaccharide | - | - | - | - | 1件: 6 6 💬
|
| 1320 | Liquigen MCT oil | - | - | - | - | 1件: 6 6 💬
|
| 1321 | Liraglutide | 1件: Liraglutide Liraglutide | 1件: Liraglutide
Liraglutide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 6 6, 13, 75, 77, 193 💬
|
| 1322 | Lisparin | - | - | - | - | 1件: 6 6 💬
|
| 1323 | LISURIDE | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 86 💬
|
| 1324 | Lisuride Hydrogenmaleate | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1325 | Lisuride Transdermal System | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1326 | Lisuride TTS | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1327 | Lisuride TTS 10cm² | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1328 | Lisuride TTS 20cm² | 1件: Lisuride Lisuride | 1件: Lisuride
Lisuride
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1329 | Lithium | - | - | - | - | 5件: 2 2, 5, 6, 7, 8 💬
|
| 1330 | Lithium aspartate | - | - | - | - | 1件: 6 6 💬
|
| 1331 | Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules | - | - | - | - | 1件: 6 6 💬
|
| 1332 | Lixisenatide | 1件: Lixisenatide Lixisenatide | 1件: Lixisenatide
Lixisenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1333 | Local Anesthesia (lidocaine hydrochloride) | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | 1件: 6 6 💬
|
| 1334 | Local Trade Name, 2mg | - | - | - | - | 1件: 6 6 💬
|
| 1335 | Local Trade Name, 4mg | - | - | - | - | 1件: 6 6 💬
|
| 1336 | Local Trade Name, 8mg | - | - | - | - | 1件: 6 6 💬
|
| 1337 | LODALÈS® | - | - | - | - | 1件: 6 6 💬
|
| 1338 | Lovastatin | 1件: Lovastatin Lovastatin | 1件: Lovastatin
Lovastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
|
| 1339 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 💬
|
| 1340 | Low Dose GT-02287 | - | - | - | - | 1件: 6 6 💬
|
| 1341 | Low dose levodopa | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1342 | Low-Frequency-Only Stimulation | - | - | - | - | 1件: 6 6 💬
|
| 1343 | Lu 00-800 | - | - | - | - | 1件: 6 6 💬
|
| 1344 | Lu AF28996 | - | - | - | - | 1件: 6 6 💬
|
| 1345 | Lu AF82422 | - | - | - | - | 2件: 6 6, 17 💬
|
| 1346 | LUBIPROSTONE | 1件: Lubiprostone Lubiprostone | 1件: Lubiprostone
Lubiprostone
💬
| 1件: CLCN2 CLCN2 💬
| 1件: Mineral absorption Mineral absorption 💬 | 5件: 6 6, 13, 97, 290, 299 💬
|
| 1347 | Lumbar puncture | - | - | - | - | 9件: 2 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
|
| 1348 | LY03003 | - | - | - | - | 1件: 6 6 💬
|
| 1349 | LY03003 ( Rotigotine, extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1350 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1351 | LY03003( the name of rotigotine) | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1352 | LY03003(Rotigotine,extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1353 | LY03009 F1 | - | - | - | - | 1件: 6 6 💬
|
| 1354 | LY03009 F2 | - | - | - | - | 1件: 6 6 💬
|
| 1355 | LY03009 F3 | - | - | - | - | 1件: 6 6 💬
|
| 1356 | LY03009 F4 | - | - | - | - | 1件: 6 6 💬
|
| 1357 | LY03017 | - | - | - | - | 1件: 6 6 💬
|
| 1358 | LY300164 | - | - | - | - | 1件: 6 6 💬
|
| 1359 | LY3154207 | - | - | - | - | 1件: 6 6 💬
|
| 1360 | LY3884961 | 1件: LY3884961 LY3884961 | - | - | - | 2件: 6 6, 19 💬
|
| 1361 | LY3962681 | - | - | - | - | 1件: 6 6 💬
|
| 1362 | LY4006896 | - | - | - | - | 1件: 6 6 💬
|
| 1363 | Madopar | - | - | - | - | 1件: 6 6 💬
|
| 1364 | Madopar 125 mg T, tablets | - | - | - | - | 1件: 6 6 💬
|
| 1365 | Madopar 125 mg, orodispersible tablet | - | - | - | - | 1件: 6 6 💬
|
| 1366 | Madopar 200+50 mg | - | - | - | - | 1件: 6 6 💬
|
| 1367 | Madopar LT | - | - | - | - | 1件: 6 6 💬
|
| 1368 | Madopar monotherapy | - | - | - | - | 1件: 6 6 💬
|
| 1369 | Madopar Tab. 125 or Perkin Tab. 25-100mg | - | - | - | - | 1件: 6 6 💬
|
| 1370 | Madopar® 125 | - | - | - | - | 1件: 6 6 💬
|
| 1371 | Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride) | 2件: Benserazide Benserazide, Levodopa | 3件: Levodopa
Levodopa
,
Benserazide hydrochloride
,
Benserazide
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1372 | Madopar® 250 | - | - | - | - | 1件: 6 6 💬
|
| 1373 | Madopar® HBS | - | - | - | - | 1件: 6 6 💬
|
| 1374 | Madopar® HBS 125 | - | - | - | - | 1件: 6 6 💬
|
| 1375 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 23件: 3 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
|
| 1376 | Magnesium oxide | 2件: Magnesium Magnesium, Magnesium oxide | 1件: Magnesium oxide
Magnesium oxide
💬
| - | - | 4件: 6 6, 113, 166, 291 💬
|
| 1377 | Magnetic Resonance Imaging | - | - | - | - | 10件: 6 6, 13, 19, 22, 28, 34, 65, 205, 285, 299 💬
|
| 1378 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin
Maltodextrin
💬
| - | - | 4件: 6 6, 13, 96, 97 💬
|
| 1379 | Mannitol | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 8件: 6 6, 13, 21, 28, 60, 96, 113, 299 💬
|
| 1380 | MANTADIX | - | - | - | - | 1件: 6 6 💬
|
| 1381 | Marketed Pramipexole ER | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1382 | MARS | - | - | - | - | 1件: 6 6 💬
|
| 1383 | MASITINIB | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 1384 | MASITINIB MESYLATE | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 1385 | Massage with a spiky ball | - | - | - | - | 1件: 6 6 💬
|
| 1386 | Mavoglurant | 1件: Mavoglurant Mavoglurant | - | - | - | 2件: 6 6, 206 💬
|
| 1387 | MC1 | - | - | - | - | 3件: 6 6, 13, 46 💬
|
| 1388 | MED ON plus | - | - | - | - | 1件: 6 6 💬
|
| 1389 | MEDI1341 | - | - | - | - | 1件: 6 6 💬
|
| 1390 | Medical Cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 3件: 6 6, 96, 97 💬
|
| 1391 | Mediterranean diet supplemented with medium-chain triglyceride oil | - | - | - | - | 1件: 6 6 💬
|
| 1392 | Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 18件: 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 1393 | MELATONIN (MELATL07959) | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1394 | Melatonin PR | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1395 | Melatonin(Circadin®) | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
| 1396 | Melevodopa | 1件: Melevodopa Melevodopa | 1件: Melevodopa
Melevodopa
💬
| - | - | 1件: 6 6 💬
|
| 1397 | Melevodopa and decarboxylase inhibitor | 1件: Melevodopa Melevodopa | 1件: Melevodopa
Melevodopa
💬
| - | - | 1件: 6 6 💬
|
| 1398 | Melperon | - | - | - | - | 1件: 6 6 💬
|
| 1399 | Melperone | 1件: Melperone Melperone | 2件: Melperone
Melperone
,
Melperone hydrochloride
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1400 | Melperone HCl | 1件: Melperone Melperone | 2件: Melperone
Melperone
,
Melperone hydrochloride
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1401 | Memantin Orion | - | - | - | - | 1件: 6 6 💬
|
| 1402 | Memantine | 1件: Memantine Memantine | 2件: Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬
|
| 1403 | Memantine (drug) | 1件: Memantine Memantine | 2件: Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1404 | MEMANTINE HYDROCHLORIDE | 1件: Memantine Memantine | 2件: Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 127 💬
|
| 1405 | Menthol gloves and socks | - | - | - | - | 1件: 6 6 💬
|
| 1406 | Mesdopetam | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 💬
|
| 1407 | Mesdopetam (IRL790) | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 💬
|
| 1408 | Mesencephalic Neuronal Precursor Cells | - | - | - | - | 1件: 6 6 💬
|
| 1409 | Mesenchymal stem cells | - | - | - | - | 16件: 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
|
| 1410 | Mestinon | - | - | - | - | 3件: 3 3, 6, 11 💬
|
| 1411 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA1 PRKAA1, PRKAA2 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 31件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 1412 | Methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
|
| 1413 | Methylphenidate (MPD) | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 1414 | METHYLPHENIDATE HYDROCHLORIDE | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 1415 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 51件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 1416 | Mg++ | - | - | - | - | 1件: 6 6 💬
|
| 1417 | Mid dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 💬
|
| 1418 | Midazolam | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 9件: Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 14件: 2 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
|
| 1419 | Midodrine | 1件: Midodrine Midodrine | 2件: Midodrine hydrochloride
Midodrine hydrochloride
,
Midodrine
💬
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 17, 58 💬
|
| 1420 | Minocycline | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 14件: 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
| 1421 | Minodronic acid | 1件: Minodronic acid Minodronic acid | - | - | - | 4件: 6 6, 46, 93, 95 💬
|
| 1422 | Minzasolmin | 1件: Minzasolmin Minzasolmin | 1件: Minzasolmin
Minzasolmin
💬
| 1件: SNCA SNCA 💬
| 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 💬
|
| 1423 | Minzasolmin (UCB0599) | 1件: Minzasolmin Minzasolmin | 1件: Minzasolmin
Minzasolmin
💬
| 1件: SNCA SNCA 💬
| 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 💬
|
| 1424 | Mirabegron | 1件: Mirabegron Mirabegron | 1件: Mirabegron
Mirabegron
💬
| 1件: ADRB3 ADRB3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 💬
|
| 1425 | Mirapex | - | - | - | - | 1件: 6 6 💬
|
| 1426 | Mirapex (pramipexole) | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1427 | Mirapex ER | - | - | - | - | 1件: 6 6 💬
|
| 1428 | Mirapex LA | - | - | - | - | 1件: 6 6 💬
|
| 1429 | Mirapexin | - | - | - | - | 1件: 6 6 💬
|
| 1430 | Mirapexin / Sifrol | - | - | - | - | 1件: 6 6 💬
|
| 1431 | Mirapexin extended release various strengths | - | - | - | - | 1件: 6 6 💬
|
| 1432 | MIRAPEXIN*30CPR 0,7MG | - | - | - | - | 1件: 6 6 💬
|
| 1433 | Mirapexin/Sifrol | - | - | - | - | 1件: 6 6 💬
|
| 1434 | Mirtazapine | 1件: Mirtazapine Mirtazapine | 1件: Mirtazapine
Mirtazapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 85, 97, 156 💬
|
| 1435 | Mirtazapine 15 MG | 1件: Mirtazapine Mirtazapine | 1件: Mirtazapine
Mirtazapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1436 | MitoQ | - | - | - | - | 3件: 2 2, 6, 97 💬
|
| 1437 | MK0657 | - | - | - | - | 1件: 6 6 💬
|
| 1438 | MOCLOBEMIDE | 1件: Moclobemide Moclobemide | 1件: Moclobemide
Moclobemide
💬
| 1件: MAOA MAOA 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1439 | MODAFINIL | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬 |